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Abstract 
Psychometric evaluation of the Mahan and DiTomasso Anger Survey (MAD-AS) 
analysis in an outpatient cardiac population is herein described. The MAD-AS is a newer 
instrument that measures the cognitive, affective, and behavioral components of anger 
and is beneficial in that it is brief. One hundred fifty cardiac outpatients and one hundred 
fifty non-cardiac dental patients were administered a demographic form that requested 
information about cardiac risk factors, the MAD-AS, and the STAXI-2, a widely used 
valid and reliable measure of state and trait constructs of anger. The MAD-AS factor 
structure, construct validity, internal consistency, and reliability were examined and 
found to support the instrument. Group differences were hypothesized to exist in regards 
to anger; these differences were not statistically significant. However, when age and 
several risk factors were controlled for, group differences were detected in the expected 
trajectory in MAD-AS scores but not in STAXI-2 scores. The results described in this 
study support the reliability and validity of the MAD-AS. 
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Chapter 1 
Introduction 
According to the American Heart Association (2004), coronary heart disease 
(CHD) has been the greatest killer of Americans each year since the early 1900's. 
Approximately every 26 seconds one person will experience a cardiac event, and each 
minute one person will die from it. In fact, about 42% of individuals who experience a 
cardiac event will die from it (AHA, 2004). CHD was responsible for 1 in 2.5 deaths in 
2001; however, identifying traditional genetic and lifestyle risk factors for heart disease 
" 
does not explain approximately 50% of cardiac diagnosis each year (Futterman & 
Lemberg, 1998; Helmekens, 1998). Thus, the search for viable correlates of heart disease 
has become vastly important. 
One of the most promising psychological correlate of he ali disease is anger, 
hostility, and aggression (e.g., Fredrickson, Maynard, Helms, Haney, Siegler, & Barefoot, 
2000; Houston, 1994; Suarez, Kuhn, Schanberg, Williams, & Zimrnering, 1998; Suls & 
Wan, 1993). These factors have emerged £Tom early research on a characteristic behavior 
pattern ternled "Type A Behavior Pattern" (also referred to as "Type A" or TABP). 
As far back as the 1950's, researchers were interested in investigating the 
psychological links to CHD and identified the T ABP, which refers to an individual who 
is very competitive, often impatient, has a strong sense of time-urgency, and who 
experiences easily aroused hostility and anger (Friedman & Rosenman, 1959; Rosenman 
et aI., 1964). Since then, much effmi has been put forth to elucidate fmiher the 
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mechanisms involved in the etiology, progression and maintenance of heart disease. 
When some studies, using more stringent research methods, did not find suppOli for the 
TABP/CHD correlation, research became focused in the 80's and 90's on anger, hostility, 
and aggression as the potent components of T ABP most associated with CHD (as cited in 
Ravaja, Kauppinen, & Keltikangas-Jarvinen, 2000). 
Although many of the pathways that may lead to CHD have been illuminated, 
agreement on how to best measure anger, hostility, and aggression has not been 
established. Coupled with that dilemma is the fact that most measurement instruments 
are quite lengthy. Thus, the development of a brief, well-validated instrument that 
successfully taps the cognitive, affective, and behavioral aspects of anger constructs is 
needed. Such an instrument may potentially be implemented as a screening tool for use 
in the primary care setting to identify at-risk individuals. Given the devastating financial 
and human impact CHD has on our society, the health of a great number of people may 
be positively affected if individually tailored treatment plans are implemented as a result 
ofthis measure. 
Purpose 
The purpose of this investigation is twofold. The principal purpose of this study 
is to add to the normative data of the Mahan and DiTomasso Anger Survey (MAD-AS), a 
newer instrument that measures the cognitive, affective, and behavioral components of 
anger. One of the chief benefits of this instrument is that it is relatively shorter than other 
surveys. Therefore, the primary goal of this study is to evaluate further psychometric 
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properties of the MAD-AS as a succinct instrument to measure the constructs of anger in 
a cardiac and non-cardiac outpatient population. Strong psychometric properties may 
introduce the possible clinical use of the MAD-AS as a screening tool when early 
interventions may positively impact the health of many at-risk Americans. 
The second purpose of this investigation is to contribute to the body of research 
elucidating significant psychological correlates of coronary heart disease. 
Rationale 
Heart Function 
The human heart, whose function is to pump blood throughout the body, is a very 
strong muscle about the size of an adult fist. Blood passes from the right side of the heart 
into the lungs where it becomes oxygenated and then returns to the left side of the heart. 
From the left side of the heart, blood is dispersed throughout the circulatory system. 
The circulatory system is made up of the heart, lungs, arteries, arterioles, 
capillaries, and venules. These structures are an incredibly long and intertwined group of 
tubes that deliver oxygen rich blood to all areas of the body. They also clean out cell 
waste products by filtering them through the lungs, liver, and kidneys. The blood travels 
throughout the circulatory system when the heart muscle contracts its four chambers in a 
specific sequence. The contractions are governed by an electrical impulse that originates 
in the right atrium, which is also called the sinus node. The electrical impulse discharges 
a signal that causes the heart to beat (Brunwald, 1992). However, all too often, a 
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multitude offactors may prevent the heart from performing its job properly, resulting in 
varying forms of coronary heart disease (CHD). 
Coronmy Heart Disease 
The broad term of cardiovascular disease (CVD) is composed of several forms of 
heart disease including hypertension, congestive heart failure, stroke, congenital heart 
defects, and coronary heart disease (CHD). CVD has been the has been the number one 
killer of Americans since the 1900's, claiming more lives each year than the other five 
major causes of death combined, including cancer, respiratory diseases, accidents, 
diabetes, flu, and pneumonia (American Heart Association, 2004). For those under the 
age of 75, more than half of all cardiovascular events are due to CHD, which makes this 
the single largest killer of Americans (AHA, 2004). 
CHD includes heart attack also called myocardial infarction (MI), angina pectoris 
(chest pain) or both. Every 26 seconds someone win suffer a coronary event and every 
minute someone will die as a result; about 42% ofMI occurrences result in death. 
Approximately 80% of deaths due to CHD in those under age 65 occur during the first 
attack. 25% of men and 38% of women will die within one year of having an MI and 
half of those under 65 who have had an MI will die within 8 years of the attack. What is 
even more troubling is the fact that 50% of men and 64% of women who have suddenly 
died ofCHD did not have any symptoms (AHA, 2004). This fact highlights the 
importance of knowing one's risk factors. 
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According to the AHA (2004)) about two-thirds ofpaticnts do not make a 
complete recovery after a heart attack, thus, CHO is also the major cause of premature, 
permanent disability in the United States workforce, accounting for 19% of Social 
Security Administration disability allowances; 10.7 billion dollars was paid to Medicare 
beneficiaries for CHD in 1999. The direct and indirect cost ofCHD alone is 133.2 billion 
dollars and for all cardiovascular diseases, the cost has been estimated at a staggering 
368.4 billion dollars. Direct costs include cost of physicians and other health care 
professionals, hospital and nursing home services, home health care) medication, and 
medical equipment. Indirect costs consist of lost productivity that results from morbidity 
and mortality. For comparison sake, the 2003 estimated cost both direct and indirect for 
all cancers is 189 billion. 
The lifetime risk of developing CHD when an individual reaches 40 years of age 
is 49% for males and 32% for females (AHA, 2004). For comparison sake, it was also 
calculated that at birth, a person's long term probability of dying fi'om CHO is 47%; 
however, the probability of dying from cancer is 22%,3% for accidents, and 0.7% for 
HIV (AHA, 2004). Given the tremendous impact CHD has on American society in 
financial terms and more importantly in terms of human suffering, it is apparent that 
identifying all potent risk factors of ClIO is essential to the health and well being of a 
tremendous number of individuals. 
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Biological and Lifostyle Risk Factors oj CWD 
Several biological and lifestyle risk factors of CHD have been established by the 
American Heart Association; these include premature family history, male sex (female 
risk is almost equal to male after menopause), smoking, overweight and obesity, physical 
inactivity, hypeliension, high cholesterol, and diabetes. Unless otherwise noted, all 
biological and lifestyle risk factor statistics were derived from the Heart Disease and 
Stroke Statistics - 2004 Update (AHA, 2004). 
Premature Jam ily history. The CHD risk factor that cannot be modified is 
premature family history. That is, a first-degree relative such as a sibling or parent, 
younger than 55 for men and younger than 65 for women, who have had CHD is 
considered a genetic independent risk factor for the disease and is not modifiable. 
Male sex. American men under the age of 74 have a greater risk of CHD than do 
women in that sanle age category. The incidence of CHD in women lags behind men by 
10 years. The lag time is attributed to hormone changes resulting from menopause. 
CHD rates in women after menopause are over 2 times higher than in women before 
menopause. Therefore, male sex status independently places middle-age men at risk for 
CHD. 
Smoking. One of the lifestyle risk factors highly related to CHD is smoking. 
Although tobacco use has declined more than 40% since 1965, smoking continues to kill 
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far too many Americans. An average of 442,398 people have died from 1995 through 
1999 from smoking-related illnesses and over 33% of those deaths were cardiovascular 
related. Even if an individual does not smoke, the health effects from tobacco can cause 
death. Approximately 35,000 nonsmokers die annually from CRD because they were 
exposed to second-hand smoke at home or at work. Including smoking-attributable lost 
productivity costs, neonatal medical expenses, and medical expenditures, smoking costs 
more than 157 billion dollars per year. 
Overweight and obesity. One risk factor of CHD that has become a topic of 
concern among many healthcare professionals is overweight and obesity. Americans are 
becoming larger at an alarming rate. The number of total calories from fat in the 
American diet has decreased over the past decade, however, the total daily caloric intake 
has increased, contributing to the swift increase in obesity. Approximately 300,000 
adults die every year from obesity-related causes. Overweight and obesity obese is 
determined by calculating one's Body Mass Index (BMI), taking weight in kilograms and 
dividing that number by height in meters squared (kg/m2). Overweight in adults is 
defined as a BMI of25 - 29.9; obesity is defined as a BMI of 30 or greater; and extreme 
obesity is defined as a BMI of 40 or greater. These numbers have risen dramatically in 
recent years. For instance, the prevalence of obesity since 1991 has increased a startling 
75%. In a similar time period from 1988 through 1994 the prevalence of overweight 
individuals has increased from 55.9% to 64.5%; obesity prevalence has gone from 22.9% 
to 30.5%, and extreme obesity in the same time period has risen from 2.9 to 4.7%. Being 
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overweight and being 0 bese are also costly conditions, estimated to cost about 100 billion 
dollars amlUally. The impact on one's lifespan is also greatly influenced. For instance, 
the lifespan of a 20 year old extremely obese white man whose BMI is greater than 45 is 
reduced by an estimated] 3 years. Thus, being overweight and being obese are clearly 
significant, modifiable threats to one's health status. 
Physical inactivity. A major modifiable risk factor that plays a role in CHD 
mortality is physical inactivity. Lack of physical activity is associated with a relative risk 
of CHD comparable to smoking, hypertension, and high cholesterol. Data from 2000 -
200] indicated that of Americans over the age of] 8, 54.6% were not active enough to 
meet physical activity recommendations. Moderate activity is defined as engaging in 
activities such as walking or bicycling at least 30 minutes on 5 days of a 7 -day period. 
Vigorous activity is defined as activities that produce heavy breathing and sweating for at 
least 20 minutes on 3 days or more of a 7 -day period. In the year] 997-1998, 38.3% of 
Americans over age] 8 reported that they did not get any physical activity at all; some 
fOlm of physical activity was reported by 61.7%, and light to moderate physical activity 
was reported by 22.7%. The annual cost related to physical inactivity is 76 billion dollars 
per year. 
Hypertension. Hypertension (High blood pressure or HBP) is defined as a 
systolic pressure of 140 mm Hg and over, or a diastolic pressure of90 mm Hg and over 
or both. There is also a condition termed "prehypertension" that refers to a systolic 
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pressure between 120-139 mm Hg, a diastolic pressure between 80-89, or both. One of 
four American adults has hypertension and approximately 22% have prehypertension. 
30% ofthose with hypertension do not know they have it, 34% are on medication for it 
and have it controlled, 25% are on medication but do not have it under control, and 11% 
are not on medication. Before the age of 55 a higher percentage of men have 
hypertension, from 55-74 women have a somewhat higher percentage, and over the age 
of 75 women have a much higher percentage of hypertension than men. 
Black Americans are disproportionately afflicted with this condition. The 
prevalence of hypertension in black Americans is the highest in the world. As compared 
with white Americans, black Americans have a 1.5 times greater rate of death from heart 
disease. 
About half of those who experience their first heart attacks have blood pressures 
that are 160/95 mm Hg or higher. Hypertension was the primary or contributing cause of 
death in over 250,000 deaths in 2000. The death rate from hypertension rose 36.4% from 
1991-2001 and the number of deaths rose 53%. The direct and indirect costs for 2004 are 
estimated to be 55.5 billion dollars. 
High cholesterol. Total blood cholesterol is determined by the measurement of 
serum cholesterol in one's blood. Levels of200-239 mg/dL are considered borderline 
high risk in adults and levels above 240 mg/dL are considered high risk. However, total 
cholesterol levels give limited information about CHD risk; a consideration of the 
breakdown of HDL and LDL gives more valuable information. HDL is considered the 
"good" cholesterol and the higher the number the better. 40 mg/dL and below is 
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considered too low and is a CHD risk factor. Conversely, LDL is considered the "bad" 
cholesterol and the lower the bettcr. A lcvel of 130-159 mg/dL is considered borderline 
high, 160-189 mg/dL is considered high, and over 190 mg/dL is considered very high. 
Adults whose good cholesterol is low and whose total cholesterol is high have the 
greatest risk of a heart attack. HDL is a very potent factor in assessing health status 
because men with lower than 37 mg/dL are at high risk of a heart attack regardless of 
their total cholesterol level. In fact, a person who has high total cholesterol still carries 
the low risk of a heart attack if even if he or she has high HDL. 
Management oflipids is problematic and adherence to treatment regimen is a 
major factor. Ifthe population had a mere 10% decrease in total cholesterol, there would 
be an estimated 30% reduction in CHD. But only 50% of those who meet criteria for 
lipid treatment for CHD risk reduction receive it. Fewer than 50% of the highest risk 
adults who have symptomatic CHD are receiving treatment. Of those who are prescribed 
lipid modifying treatment only about 50% continue to take it six months after it is 
prescribed; this is a dilemma because it takes up to a year before the medications change 
lipid profiles. 
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Diabetes. Diabetes is defined as a fasting blood glucose level greater than 126 
mg/dL. The rate of diagnosed diabetes continues to rise in America. In fact, the 
prevalence of diabetes has increased 61% since 1990. During the year 2000, of the 4.4 
million adults who had diabetes, 2.9 million were diagnosed with CHD. CHD death rates 
for diabetic adults are 2 to 4 times greater than non-diabetic adults, and up to three 
fourths of adults diagnosed with diabetes die from a heart or blood vessel disease. 
However, accounting for all of these aforementioned risk factors still leaves a 
great percentage of CHD unexplained (Kannel & Schatzkin, 1983). Therefore, 
considerable effort has been made in identifying other salient psychological risk factors. 
Research in this area began with the identification of TABP and has progressed through 
the years to identify more specifically the most fruitful ofthese risk factors: anger, 
hostility, and aggression (Smith, 1992). 
Psychological Factors and eHD 
The progression to heart disease does not occur quickly and it is not an inevitable 
result of the aging process. It is often, but not always, without symptom at the onset of 
atherosclerosis; it is often followed by warning signs such as angina, and then progresses 
to events such as heali attack or sudden death. The average age of a first heart attack is 
65.8 for men and 70.4 for women (AHA, 2004). The disease process generally spans 
many years of risk factors interacting with various biochemical, inunune inflanunatory 
and hemodynamic processes before symptoms manifest themselves (Krantz & McCeney, 
2002). It is a progressive situation because the mind and body continually interact 
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through the system's autonomic nervous system, musculoskeletal system, and the 
psychoneuroendocrine system (Buselli & Stuart, 1999); therefore, risk factors and disease 
operate in a bi-directional manner. Thus, considering one's psychological risk profile 
utilizing the biopsychosocial model (biological factors, psychological factors, and 
social/environmental factors) are as important in a complete picture of health status as are 
an assessment of only genetic and lifestyle risk factors. 
Type A Behavior Pattern (IABP) 
Early research studies that examined psychological links to CHD (Friedman & 
Rosenman, 1959; Rosellllan et aI., 1964) identified a specific characteristic pattern that 
appeared to be related to CHD; this was temled Type A Behavior Pattern or;rABP. This 
phrase became a highly publicized buzz- word that is still today a well- known term. It 
refers to an individual who is extremely competitive, often impatient, has a strong sense 
of time-urgency, and is often hostile and angry. TABP individuals display chronic 
activation, hence they are keyed up and stay keyed up most of the time. They are also 
multiphasic, meaning they usually do more than one thing at a time (Wright, 1988). This 
concept received considerable support and the correlational association was a strongly 
held notion for many years. For instance, a quantitative meta-analysis determined TABP 
to be significantly associated with CHD (Booth-Kewley & Friedman, 1987), and some 
studies have been able to demonstrate that TABP individuals have more than 2 times the 
incidence ofCHD (Friedman, et aI., 1986; Haynes, Feinleib, & Kannel, 1980). However, 
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over time, because several studies using more stringent research methods (Hearn, 
Murray, & Luepker, 1989; Leon, Finn, Murray, & Bailey, 1988), did not tind support for 
TABP, some researchers advocated the abandonment of the TABP concept altogether 
(e.g. Conduit, 1992). Instead, more focused investigations began to isolate the most toxic 
II 
aspects ofTABP that were responsible for the link to CHD. The factors that began to 
emerge as being significant are anger, hostility, and aggression. 
Anger 
The emotion of anger has been a rich topic of research for decades. Theories 
abound about the complexities of the anger experience. Early theorists debated one of 
the most fundamental aspects of anger: how does one come to experience the emotional 
feeling and physical reaction of anger? This debate began in eamest when psychologist 
William James coLlaborated with physiologist Carl Lange and concluded that aversive 
stimuli produces distinct physical reactions (e.g. increased heart rate and respiration, 
tightened facial muscles) particular to each emotion and that once the individual 
perceives these physical sensations they then attribute them to the feeling of anger. 
Simply put, the James-Lange theory (as it has been termed) states that physical sensation 
precedes the emotion (Lange & James, 1922). 
Conversely, two physiologists, Walter Cannon and Philip Bard came to the 
opposite conclusion. Their theory (Cannon, 1929) posited the idea that physiological 
reactions were not specialized to each specific emotion. One could experience sweating 
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and a racing heart for various reasons such as love, anger, or fear. They believed that 
bodily sensations are a result of the body's "fight or flight" response (the neuroendocrine 
activation that prepares the body to flee or deal with severe bodily injury) and that these 
sensations are more universal. In the Cannon and Bard conceptualization, feelings and 
sensations occur simultaneously. Accordingly, research has continued throughout the 
years in attempts to understand the mechanisms involved in the experience of anger. 
Anger is often perceived as a negative emotion (Watson & Clark, 1991) that is 
undesirable to express. Indeed, uncontrolled control anger can lead to crime, violence, 
and other destructive behavior. The reality is that anger is a very important adaptive 
function, a normal response to a threatening situation. When such a situation occurs, 
anger can be positively directed to guide our actions. If not for the fight or flight 
response, the human race would not have survived. If an individual could not fend off or 
flee from an attacking lion that person would be eaten, thus, the fight or flight response 
has served us well. 
In a social situation anger is conceptualized as just as adaptive in responding to a 
threat (Beck, 1999). One could perceive a verbal assault as being just as deleterious as a 
physical assault and prepare to protect oneself. These are all positive and appropriate 
signals that guide one's actions and are part of everyday life. However, distinguishing 
between healthy and toxic anger behaviors has revealed interesting results. For instance, 
a systematic literature review of prospective studies from 1980 to 2000 has found 
empirical evidence stating that emotions such as anger are linked to CHD (Tennant & 
McLean, 2001). On the other hand, the principal aspect of the anger experience that is 
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most health threatening continues to be debated. For example, it has been proposed that 
it may be the frequency and persistency of physiologic activation that is more related to 
disease progression (Herrald & Tomaka, 2002) and not the mere experience or severity of 
anger. It has also been suggested that the outward, clu-onic, full-blown expression of 
anger is pathogenic, not simply the experience or suppression of the anger (Siegman & 
Snow, 1997). In support ofthe anger expression theory, it has been concluded that 
patients with CHD who expressed anger outwardly and who experienced low social 
support were at a highly increased risk of disease progression, a risk that was independent 
of other risk factors and medications (Angerer, Siebert, Kothny, Muhlbauer, Mudra, & 
von Schacky, 2000). Hence, the search for clarity in the role through which emotions 
relate to CHD has continued and has pointed to anger, hostility, and aggression constructs 
as salient factors. 
When Helmers et al. (1993) examined hostility and CHD risk, they distinguished 
between various types of hostility (high, low, defensive) to look at possible differences. 
It was observed that those who were categorized as high hostile showed the most severe 
ischemia, therefore, the most negative health prognosis. When women were studied to 
explore the relationship of hostility to lipid profile, those with high antagonistic hostility 
scores (as opposed to cynical and neurotic hostility) had higher cholesterol levels 
(Suarez, Bates, & Harralson, 1998). Moreover, a meta-analysis examining hostility and 
physical health found that hostility has been observed to be an independent risk factor for 
CHD (Miller, Smith, Turner, Guijarro, & Hallet, 1996). This is suggestive of a 
pathophysiolgical mechanism between hostility and CHD which is similar to anger. 
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There is no doubt that the conceptual clarity provided by the STAXI concerning anger 
and hostility have been invaluable in elucidating the link to CHD, specifically in 
delineating the state vs. trait dimensions of these concepts, 
State/Trait Distinction 
Research on anger and hostility has been confusing because of vague definitions 
of the constructs and the interchangeable use of terms. Spielberger (1988; Spielberger, 
Reheiser, & Sydeman, 1995) made an important distinction when he and his colleagues 
separated the concept of state anger from trait anger and developed the State-Trait Anger 
Expression Inventory (STAXI) (Spielberger, 1988) and its updated version, the STAXI-2 
(SpieJberger, Reheiser, & Sydeman, 1995). Spielberger holds that the state/trait 
distinction is essential in understanding what constitutes an emotional state that is 
situation ally driven (state) versus an enduring predisposition (trait) to respond in a celiain 
manner. State anger is conceptualized as a transitory emotion with varying intensities. 
Trait anger is conceptualized as an enduring pattern of responding with higher intensity 
of anger to problematic situations, accompanied by the activation of the neuroendocrine 
system and autonomic nervous system. This distinction has been crucial in 
understanding the concepts of anger, aggression and hostility and the possible 
relationship to CHD. 
Deffenbacher and colleagues (Deflenbacher et al., 1996) posit that if one is to 
understand trait anger as an anger-prone disposition, then five theoretical predictions 
follow for an individual with high trait anger. These predictions include: (1) Elicitation 
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Hypothesis: There is a tendency to be angered easily. (2) Intensity Hypothesis: There is a 
tendency to respond more intensely when provoked. (3) Negative Expression Hypothesis: 
There is a tendency to express anger in less adaptive ways, which leads to more frequent 
anger suppression and negative anger suppression of anger, as well as less adaptive 
coping. (4) Consequence Hypothesis: Due to more frequent and intense anger and fewer 
coping skills, there is a tendency to encounter more frequent anger-related consequences. 
(5) Discrimination Hypothesis: There is a tendency to relate more easily to anger-related 
constructs than any other emotion. Eight studies were conducted (Deffenbacher et aI., 
1996) to test these hypotheses and all five theories were supported. Evidently, high trait 
angry individuals deal with negative fallout due to negative expressions of anger, 
increased volatility, and unconstructive methods to deal with situations. One of the most 
dangerous consequences of this disposition is the development of CHD. Several large-
scale research studies have confirmed this hypothesis (Chang, Ford, Meoni, Wang, & 
Klag, 2002; Williams, Paton, Seiger, Eigenbrodt, Nieto, & Tyroler, 2000). 
Another benefit of the STAXI was that it made a clear distinction between anger 
aggression and hostility. It is suggested that deficiencies in measuring such concepts are 
due to overlapping concept definitions (Arthur, Garfinkel, & Irvine, 1999); tlus was 
partially responsible for the resulting abandonment of the T ABP concept. The STAXI 
delineated the fact that anger constitutes an emotional state that varies from mild 
aggravation to intense rage with accompanying physiologic responses; hostility is 
composed of negative attitudes including meanness and viciousness, and aggression 
includes aggressive and vindictive behaviors. In addition, anger is generally 
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conceptualized as a feeling and hostility and aggression invol ves negative attitl1des and 
behavior. Thus, it is understandable that research into anger is often confounded because 
the constructs of anger, hostility, and aggression are intrinsically related yet are very 
unique. Barefoot (1992) defined hostility as the predisposition towards antagonistic 
behavior, with a preponderance of angry and cynical thoughts and feelings. Because 
hostility was exposed as a possible risk factor of CHD and separate from T ABP, it has 
prevailed as a critical link to the disease (Dembroski, MacDougall, Costa, & Grandits, 
1989; Williams, Haney, Lee, Kong, Bluementhal, & Whalen, 1980). High hostility 
scores were found, in early research, to be a factor in significant increases in clinical 
coronary events (Barefoot, Dahlstrom, & Williams, 1983; Shekelle, Gale, Ostfeld, & 
Paul, 1983) separate from T ABP. Since that time, more recent investigations have been 
conducted and these investigations have found hostility, along with anger and aggression, 
to be a potent health threat. 
Anger, Hostility, and Aggression (AHA! Syndrome) 
The anger - hostility - aggression components within TABP began to emerge as 
the most salient constructs that were predictive psychological correlates of CHD; these 
are referred to as the AHA! Syndrome. One study found that the AHA! Syndrome was 
directly related to total serum cholesterol and low-density lipoprotein (LDL) in men 
(Richards, Hof, & Alvaregna, 2000). LDL is also known as "bad cholesterol" and as 
previously mentioned, it is healthy to have this at a low level; however, high-density 
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lipoproteins (HDL) are commonly refelTed to as "good cholesterol" and this number 
should be high for heart health. These findings suggest that the disposition (trait) to 
express an angry affect may be a risk factor for developing CHD via an unfavorable lipid 
profile, Although the relationship between serum lipids and CHD remains quite 
complex, Van Doornen (1997) concluded that there is a relationship between the two 
factors, even when mediating lifestyle variable are controlled, Without the STAXI 
state/trait anger conceptualization, the AHA! Syndrome in relation to CHD may not have 
been identified. This distinction has directed the vast amount of research into 
psychological cOlTelates of CHD. 
Related Research 
The Precursors study. The Jolms Hopkins Precursors Study, a large prospective 
longitudinal study of 1,055 males followed participants for a period of time from 32 to 48 
years (Chang, Ford, Meoni, Wang, & Klag, 2002). The original study began in 1946 and 
consisted of 1,337 medical students who graduated from medical school in the years from 
1948 through 1964. Student participants underwent physical examinations, completed 
personal and family histories, and completed questionnaires on health status, behaviors, 
and stress reactions. Every 5 years the participants were followed up via mailed surveys, 
with a 90% response rate. The vital status of the participants is known for over 99% of 
the entire cohort. When women, those who did not respond and those who reported heart 
disease before graduation were excluded, 1,055 male participants remained for analysis. 
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Anger was assessed using the Habits of Nervous Tension Questionnaire (Thomas, 
1977). This measure asks "Whenever you find yourself in situations ofulldue pressure or 
stress, how do you usually react?" and then provides 27 items to check. Three factors 
were identified through factor analysis as anger: 1) expressed or concealed anger, 2) 
irritability, and 3) gripe sessions. The validity ofthis measure was corroborated by its 
significant correlation with the Multidimensional Anger Inventory (Siegel, 1986) total 
score and subscale scores of Anger-In, Anger-Arousal, Hostile Outlook, and Range of 
Anger-Eliciting Situations. When the Habits of Nervous Tension Questionnaire was 
administered again in 1992, approximately 43 years after graduation, the 3 previously 
described items remained clustered, suggesting that the same anger constructs were 
assessed in both administrations. Outcome analysis was performed using premature 
CHD (before age 55) and total CHD (defined as MI, sudden death, angina, ischemic heart 
disease, and any other heart disease that entailed heart bypass surgery, coronary 
interventions, hypertensive heart disease, heart failure, cerebrovascular disease, 
atherosclerosis, aortic aneurysm, peripheral vascular disease, and arterial embolism). 
High and low anger as the independent variable, age, and the relationship to premature 
and total CHD was analyzed. A substantial effect was observed between high anger 
response to stress in early life and premature CHD later in life; this was true especially 
MI in men, supporting the anger correlate of CHD. 
ARIC study. The Atherosclerosis Risk in Communities (A RIC) study conducted 
by the National Heart, Lung, and Blood Institute (NELB) is a large ongoing population-
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based prospective study of CHD, utilizing both cohort and surveillance components in 
the design (ARIC Investigators, 1989). Participants were 14,348 white and black males 
and females between the ages of 45 and 64 at baseline data collection from 1987 to 1989. 
The U.S. communities chosen to participate using random probability sampling 
procedures were Jackson, Mississippi; Washington County, Maryland; Minneapolis, 
Minnesota, and Forsyth County, North Carolina. Annual morbidity and mortality 
surveillance, as well as triennial clinical examinations have taken place. 
A study was conducted on the follow-up period from1990 to 1992 to the end of 
1995; the study examined the incidence ofCHD events of the ARIC participants 
(Williams, Paton, Seiger, Eigenbrodt, Nieto, & Tyroler, 2000). Of the 14,348 
participants, 13,208 were free of CHD at the second follow-up period. Once exclusions 
for missing and/or incomplete data were made, 12,986 participants remained to be 
analyzed. A CHD incident was operationally defined as having an acute MIl fatal CHD, 
silent MI, or cardiac revascularization procedures. All CHD events were validated by 
documented clinical evidence (e.g. ECG's and cardiac enzymes) and by coroner or 
medical examiner's reports. Trait anger was assessed using the Spielberger Trait Anger 
Scale (Spielberger, Jacobs, Russell, & Crane, 1983). The overall trait anger score (from 
minimum of 10 to a maximum of 40) was stratified into three levels; 10 - 14 low trait 
anger, 15 - 21 moderate trait anger, and 22 - 40 high trait anger. Of all the traditional 
risk factors for CHD (e.g. smoking, diabetes, overweight, hypertension), only 
hypertensive status was found to correlate statistically with high trait anger scores. It was 
found that high trait anger placed normotensive participants at significant risk for CHD 
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death and morbidity, independent of established risk factors. Using proportional hazard 
regression analysis to calculate Hazard Ratios (HRs), the study found that high trait anger 
participants were 2.61 more likely to experience a CHD event than low trait anger 
participants. Participants who were in the moderate range for trait anger had a 40% 
greater risk for a CHD event compared with low trait anger participants. Also, it was 
found that the risk of experiencing a "hard" event (acute MI/fatal CHD) was almost 3 
times greater in high trait anger participants compared with low trait anger counterparts. 
The risk of high trait anger leading to CHD in hypertensive participants did not prove to 
be statistically significant. Thus, the researchers analyzed whether or not blood pressure 
medication use (beta-blockers, calcium channel blockers, ACE inhibitors, diuretics) or 
other medications (aspirin, other antihypertensives, antianxiety medications, and 
antidepressants) could have impacted the results. It was found that hypertensive status, 
regardless of participants' use or non-use of the aforementioned medications, did not 
correlate with the anger ~ CHD risk. This confounds the angerlCHD correlation because 
it was found to be significant only for those with normal blood pressure. Hence, the 
biological pathways involved in the anger - CHD process continue to be quite complex 
and thus far elusive. 
Determinents of Myocardial Infarction Onset study. The Determinents of 
Myocardial Infarction Onset Study (Onset Study) assessed whether or not anger outbursts 
can trigger a nonfatal acute MI (Mittleman, et. aI, 1995). The study utilized a case-
crossover design, a new epidemiological technique developed for the study. In this 
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design, each case serves as is its own controL The design allows researchers to assess 
change in health risk because of exposure to a brief but hazardous period based on the 
patients' past exposure experiences. The Onset Study, which was conducted at 45 sites in 
the Boston area between August 1989 and March 1993 included 1,623 MI patients. 
Interviewers were trained in person, with a manual, with a video, and with feedback from 
the study coordinator. In addition, one-third of the interviews were audio taped and 
checked for accuracy. The interviewers were not told about the hypothesis concerning 
the "hazard period" in order to ensure non-biased interviewing. Information was 
gathered about the time, place, pain and other symptoms, estimation of frequency of 
exposure to anger in the preceding year, and the timing and intensity of anger, as well as 
other potentially hazardous factors in the preceding 26 hours before the onset of the ML 
Anger was assessed using an anger onset scale and the state anger subscale ofthe State-
Trait Personality Inventory. The ratio of exposed frequency and expected frequency 
(from the control infonnation) of the hazard period was calculated to determine an odds 
ratio of relative risk. The anger onset scale identified 39 patients who had anger episodes 
in the 2 hours before ML The relative risk calcuJated for MI after anger was 2.3 (95% 
confidence interval). This was supported by the state anger subscale that was found to 
have a 1.9 (95% confidence interval) relative risk. However, use of aspirin and beta 
blockers reduced this risk. Thus the study authors concluded that episodes of anger can 
indeed trigger a heart attack, but that some medications may reduce the risk. 
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SHEEP study. Another case- crossover designed study that was conducted was 
the Stockholm Heart Epidemiology Program (SHEEP) that also assessed whether or not 
anger outbursts can trigger a nonfatal acute MI (Moller, Hallqvist, Diderichsen, Theorell, 
Reuterwall, & Ahlborn, 1999). This study included alJ cases of nonfatal, first MI's in 
Stockholm County, Sweden from April 1993 to December 1994. Participants' ages 
ranged from 45 to 70 years old. After exclusion of cases (missing data, unreliable 
information, fatality), 660 cases were left for analysis. Interviews were conducted by 
trained nurses while the patient was in the hospital or soon after patient discharge. The 
nurses used a training manual and individual instruction to maintain conformity. To 
control for recall bias, interviewers were not told about any hypothesis regarding the 
length of time between an anger episode and an MI. They were asked only to pay 
attention to the 26 hours preceding the cardiac event. Information was gathered on 
particul ars such as time, type, circumstances, symptoms, and circumstances four days 
preceding the MI. The relative risk ofMI during a 1- hour period after an intense anger 
episode was reported as 9.0(95% confidence interval). The trigger effect was increased 
for patients who reported their usual behavior as non-hostile. Use of aspirin and beta 
blockers were again observed to diminish the risk as in the Onset Study. 
This study along with the Onset Study solidified psychological factors as potent 
triggers capable of affecting the heart, but the mechanisms by which this occurs is not 
clear. Several theories have been posited; these attempt to describe the pathophysiology 
between psychological factors and CHD. 
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Pathophysiologic Theories 
There has been a dramatic increase in the 1990's of studies that examine 
psychological cOlTelates of disease. A large-scale review of the field of 
psychoneuroimmunology examined studies published from 1939 to the present (Kiecolt-
Glaser, McGuire, Robles, & Glaser, 2002). This review concluded that there is sufficient 
evidence that psychological factors interact with biological outcomes via the immune 
system. The studies clustered into themes such as stress, negative emotion, personality, 
and immune responses, and as a result pathophysiological theories have developed. 
Some of these pathways have received support and directed new hypothesis for future 
research. Key pathophysiologic theories that deal with CHD are elevated cardiovascular 
reactivity (CVR), inflammation, and platelet aggregation. 
Elevated cardiovascular reactivity (CVR). Although investigations into anger 
and hostility have indicated a relationship to CHD (e.g., Fredrickson, Maynard, Helms, 
Haney, Siegler, & Barefoot, 2000; Houston, 1994; Suarez, Kuhn, Schanberg, Williams, 
& Zimmering, 1998; Suls & Wan, 1993), the pathophysiology is not clear. One of the 
hypothesized pathways leading to CHO that has been examined is sustained elevated 
cardiovascular reactivity (CVR) (Linden, Earle, Gerin, & Christenfield, 1997; Williams 
& Barefoot, 1988). The link is thought to be related to the repeated experience of the 
fight or flight response (Booth-Kewley & Friedman, 1987) through the experience of 
anger. Anger induces the body to release epinephrine (Suarez, Kuhn, Schanberg, 
Williams, & Zimmemlan, 1998; Suarez, Shiller, & Kuhn, 1997), and vasodilatation 
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occurs in response to the epinephrine release in preparation for action (an adaptive 
function). This becomes problematic over time when the response occurs often and there 
is a lengthy resolution period to the previous non-aroused state (a maladaptive 
consequence of anger and hostility). Indeed, research has shown that the vascular spasms 
that occur due to anger reduce coronary vascular reserves (Boltwood, Taylor, Burke, 
Grogin, & Giacomini, 1993); thus, repeated exposure to the fight or flight response may 
become a health risk. In suppOIi of this hypothesis, a three-year prospective study 
(Markovitz, Matthews, Wing, Kuller, & Meilahn, 1991) measured anger and physical 
health in middle- aged women. This investigation found higher systolic and diastolic 
blood pressure in women who had higher Spielberger Trait Anger scores (Spielberger, 
Jacobs, Russell, & Crane, ] 983) even when traditional risk factors were controlled. 
Because activation of the fight or flight response is involuntary, examination of 
causal forces such as anger and hostility have been a logical target for intervention. In 
fact, in a random sampling of 1,478 coronary artery diseased patients, it was observed in 
controlled, long-term studies that those randomly chosen patients who received therapy 
aimed at altering hostile behavior (stress management), in addition to receiving 
traditional care demonstrated a reduction in myocardial re-infarction and mOliality risk 
by approximately 50%, a decrease in myocardial ischemia, and an 8% decrease in 
coronary diameter (Blumenthal, et al., 1997; Frasure-Smith & Prince, 1989; Friedman, et 
al., 1986; Omish, et al., 1998). A 28% increase in coronary diameter was observed in the 
controls who received standard medical care only. These studies highlight the need to 
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consider psychosocial aspects of an individual in addition to biological factors in optimal 
health care. 
Another study (I,'riedman, Breall, Goodwin, Sparagon, Chandour, & Fleishman, 
1996) found that patients who had CHD and silent ischemia diagnosed by Holter monitor 
reduced daily ischemic episodes by 50% following counseling for hostility and time 
urgency. Although it seems at face value to be a clear causal relation, there is nothing 
clear-cut about the connection. Indeed, the pathway to disease remains quite complex. 
Inflammation. Atherosclerosis is often conceptualized as accumulation of plaque 
or fat within artery walls. When the accwnulation becomes large enough, it can block 
blood flow possibly leading to CHD. However, atherosclerosis is not a passive 
circumstance. Atherosclerosis involves inflammation at every step of the disease 
process, because the endothelium (cell lining) does not function nonnally due to the 
inflammation process (Ross, 1999). The inflammation process may interrupt the 
endotheliwn of the artery and eventually lead to a rupture of the plaque. This can 
subsequently initiate an ML 
Vascular biology has demonstrated how C-reactive protein (a measure of 
inflammation) can predict CHD risk beyond traditional risk assessment. The Physicians' 
Health Study (Ridker, Cushman, Stampfer, Tracy, & Hennenkens, 1997) compared 543 
subjects without MI or stroke with 543 subjects who developed CHD over the eight- year 
follow-up period. All subjects were randomized at the beginning of the study either into 
an aspirin group or a placebo group. The study found that the men who later had an MT 
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had significantly higher levels of C-reactive protein at baseline. The researchers 
concluded that the measurement of inflammation via C-reactive protein levels was a 
predictor of future MI independent of traditional risk factors. 
Production of C-reactive protein has been found to increase with negative 
emotion. This is accomplished by emotion's effect on the immune system, which, in tum 
regulatQs the production of C-reactive protein. For instance, aggression was found to 
correlate significantly with T- and B- cell counts (immune function markers) in male 
military perso:nnel regardless of age, health, or testosterone levels (Granger, Booth, & 
JOMson, 2000). Thus, CHD onset and progression is thought to be affected by negative 
emotion via the immune system's overproduction or under production of C-reactive 
protein. 
Platelet Aggregation. Another pathophysiologic theory that has received support 
is platelet aggregation in response to anger. Wenneberg and colleagues (1997) found 
significant and positive correlations between anger expression and platelet aggregation. 
They posit the idea that exaggerated sympathetic nervous system response (fight or 
flight) results in a surge of catecholemines in the cardiovascular system, which 
encourages platelets to aggregate (get "sticky"). The platelet aggregation can lead to 
occlusive thrombus (blockage) formation in those who are susceptible. 
A study by Markovitz (1998) supported this hypothesis when it was found that 
participants who displayed the greatest anger had increased platelet reactivity and 
hyperaggregability. This finding led the researchers to posit the further idea that it may 
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be the expression of anger that is the most health detrimental component, rather than the 
mere experience of anger. 
This view is also held by Seigman (1993) who examined CHD in relation to anger 
suppression, anger expression, and anger experience. That investigation reported that it 
is the chronic expression of anger, not the experience or suppression of anger that was 
found to be a risk factor for CHD. The important term for consideration is "chronic" 
expression of anger, because this distinction alludes to a direction in research that has 
helped clarify state (temporary) from trait (enduring) anger and hostility. 
Research continues to demonstrate the fact that to do a better job at preventing 
CHD, health care professionals must not rely solely on conventional risk factors. For 
instance, a study examining over 120,000 patients who suffered an acute MI found that 
53% of women and 62% of men had 0 or 1 traditional risk factors (Khot, et. aI, 2003). 
This leaves a great number of Americans at risk for CHD even if they know and assess 
conventional risk factors. 
Although no defmitive agreement on the biopsychosocial relatedness to CHD 
exists, enough evidence has been collected throughout the years to prompt the American 
Heart Association to add psychosocial evaluation and intervention into its Core 
Components of Cardiac Rehabilitation/Secondary Prevention program (AHA, 2000). 
This makes it aU the more necessary to develop psychometrically sound measurements of 
these constructs such as anger, which is related to the primary goal of the present study. 
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Research Hypothesis 
1) The MAD-AS will be composed of several components of anger including (a) 
Anger Dyscontrol; (b) Angry Cognitions; (c) Verbal Expressions of Anger; 
(d) Physiological Arousal; ( e) Anger J ustificationlBlame; (f) Externalization 
of Anger; and (g) Difficulty with Anger Resolution. 
2) It is hypothesized that the MAD-AS total scale will significantly correlate 
with the STAXI-2 total scores, a well-established and widely used anger 
instrument in clinical adult medical outpatient sample. 
3) The MAD-AS will demonstrate acceptable levels of alpha co-efficient 
reliability (between .70 and .90) for both total scores and also tor subscale 
scores. 
4) Subscale scores of the MAD-AS and STAXI-2 will significantly correlate. 
5) The experimental cardiac group will demonstrate higher MAD-AS total scores 
and STAXI-2 total and trait anger scores than the non-cardiac control group. 
6) Experimental cardiac group patients will demonstrate higher scores on the 
MAD-AS subscales than the non-cardiac control group. 
7) The MAD-AS will demonstrate acceptable test-retest reliability (greater than 
.80). 
Participants 
Chapter 2 
Methods 
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Participants in the experimental group consisted of one hundred and fifty adult 
male cardiac outpatients between the ages of 35 and 63 who were recruited from a private 
cardiology practice. This age range was utilized because it is within the normed age 
range of the STAXI-2 (Spielberger, 1999) and it approaches the age range at which CHD 
is the predominant cardiovascular event (American Heart Association, 2004) in those 
with cardiac problems. Participants in the control group consisted of one hundred and 
fifty male non-cardiac patient adults recruited from a private dental practice; they were 
also between the ages of35 - 63. The general demographic profile of the two geographic 
areas of the practices were found to be similar in total population, age, sex, racial 
composition, educational attainment, occupation, and SES according to the 2000 Census 
data. 
Description of Measures 
Demographic form. A demographic form which was utilized in this study is 
provided in Appendix A. Questions were derived from the CHD risk factors established 
by the AHA and include smoking, overweight and obesity, physical inactivity, 
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hypertension, premature family history, high cholesterol, and diabetes. The directions 
requested that the participants complete the survey by checking the appropriate answer. 
Questions for the cardiac group began with the participant's age, sex, and marital status. 
Next followed questions about cardiac history: i.e., whether or not participants were 
diagnosed with a cardiac condition; whether or not they had a congenital condition 
("have you had a heart condition since birth"); whether or not participants cUlTently took 
medication for a cardiac condition and if so which ones they were taking (ACE 
inhibitors, calcium channel blockers, beta-blockers, diuretics, aspirin, or more than one 
medications). lfthe cardiac condition was congenital, the protocol was not utilized in 
data analysis because the likelihood that behavior factors were related to the heart defect 
was considered minimal. General medical history questions followed; these included 
participants' risk factors for heart disease: diabetes; high cholesterol (less than 200; 200 -
239; Above 240); whether or not participants smoked (less than a pack a day or more 
than a pack a day); whether or not participants exercised (moderate or vigorous); whether 
or not participants were overweight (10- 20 lbs; 20-30lbs; Over 301bs); and whether or 
not patients had a family history of heart disease. Participants were also asked if they had 
hypertension and if so the medications they were taking to lower it. Medications to lower 
blood pressure may attenuate anger experience and/or expression. For examplc, these 
medications (beta blockers) are used for performers who have difficulty with stage fright 
(Davidson, 2003). Participants were then asked if they were currently in psychological 
counseling or currently taking antianxiety or antidepression medication, again possible 
factors than may impact anger experience and/or expression. Participants were tin ally 
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asked if they had any other m~i or illness such as cancer or organ lailure. Because the 
purpose oftlils study was to examine the anger/heart disease correlation, those protocols 
where these items were endorsed were not used in the data analysis. 
The demographic sheet in the non-cardiac group differed only in the fact that 
participants were not asked about congenital heart illness, family history of heart disease, 
or heart medications because participants with a cardiac diagnosis were not utilized in the 
statistical analysis. As in the experimental cardiac group, those participants who 
endorsed the item indicating a serious medical condition such as cancer or organ failure 
were not utilized in tIlls study. All other previously mentioned questions asked of the 
cardiac population were asked of the non-cardiac population. 
STAXI-2. The State-Trait Anger Expression Inventory (STAXI-2) is a 57 item 
updated inventory (Spielberger, 1999) of the State-Trait Anger Expression Inventory 
(STAXI) (Spielberger, 1988). The STAXI-2 is a measure of the expression, experience, 
and control of anger. It was developed to evaluate anger's role in the development of 
physical illness such as heart disease, cancer, and hypertension. The inventory comprised 
six scales, five subscales, and an index of anger expression. Anger itself is 
conceptualized as having two major components, state and trait anger. State Anger (S-
Ang) is conceptualized as a temporary psychobiological condition influenced by 
circumstance that varies from mild to intense. The S-Ang scale measures how intensely 
one experiences anger at the moment as well as the wish to express anger at the moment. 
The subscales of State Anger include Feeling Angry (A-Ang/F), measuring how intensely 
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a person is feeling angry at the moment; Feel Like Expressing Anger Verbally (8-
AngfV), measuring how intensely one wishes to express anger verbally at the moment; 
and Feel Like Expressing Anger Physically (S-Ang/P), measuring how intensely one 
wishes to express anger physically at the moment. Trait Anger is conceptualized as a 
more enduring mode of responding to situations in a similar manner, which includes 
heightened cmger arousal. Individuals with high Trait Anger experience anger more often 
and with greater intensity than those with low Trait Anger. The TraitAnger (T-Ang) 
scales measures how often one experiences anger over a period of time. S ubscales of T-
Ang include Angry Temperament (T -Ang/T) that measures the proclivity to experience 
anger without provocation; and Angry Reaction (T-AngfR) that measures how often 
angry feelings are experienced in frustrating situations or situations that involve negative 
evaluation. The Anger-Out Scale (AX-O) measures an individual's preference to exhibit 
the expression of anger either verbally or in a physically aggressive manner. Conversely, 
The Anger-In Scale (AX-I) measures how often angry feelings are repressed and not 
expressed. The Anger Control-Out Scale (AC-O) measures the attempt to control the 
expression of anger. The Anger Control-In (AC-I) measures how often one tries to gain 
control of the desire to express anger by gaining a sense of calmness following an angry 
episode. The Anger Expression Index (AX Index) is an overall index based on 
responses ofAX-O, AX-I, AC-O, and AC-L 
The ST AXI-2 is an easy to administer and easy to score instrument with strong 
psychometric properties. The ST AXI-2 was repOlied to have a high internal consistency 
of .88 (Spielberger, 1999). Normative data for the measure is based on 1,900 
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hospitalized psychiatric patients (N = 276; 105 females, 171 males) and non-psychiatric 
patient adults (N = 1,644; 977 females, 667 males). The mean age of the normal adult 
sample was about 27 years old and the age range was 16 to 63. Psychological 
Assessment Resources (PAR) owns the copyright for the ST AXI-2, thus all test materials 
(booklets, manual, answer sheets) were purchased through PAR. 
MAD-AS The Mahan and DiTomasso Anger Scale (MAD-AS), a 43- item anger 
scale (Mahan, 2001) that measures the cognitive, aiJective, and behavioral constructs of 
anger was developed in the quartet style of the Beck inventories (e.g. Beck, Epstein, 
Brown, & Steer, 1988). Thus, each item has four sentences that assess a certain aspect of 
anger and the participant rates each question on a four-point scale ranging from zero to 
three. Only items that received 100% agreement by experts in the field were chosen for 
this instrument. 
The normative sample of the original MAD-AS investigation (Mahan, 2001) 
consisted of 3 groups of 60 participants, totaling 180 participants. Group 1 consisted of 
an inpatient psychiatric population (N = 60; 34 females, 26 males). Group 2 consisted of 
an outpatient psychiatric population (N = 60; 39 females, 21 males). Group 3 consisted 
of graduate students and nurses (N = 60; 50 females, 10 males). 
Factor analysis of the scale suggests that it successfully measures cognitive, 
aflective, and behavioral components of anger. High internal consistency for the entire 
scale was reported in the preceding three studies of the MAD-AS and were as follows: 
.96 (Mahan, 2001), .90 (Martin, 2002), and .94 (Beardmore, 2003). This scale is 
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advantageous because it is briefer, therefore easier to administer than other anger 
measurements. Permission to use the MAD-AS, obtained from Dr. DiTomasso and Dr. 
Mahan, is provided in Appendix B. 
Procedures 
Experimental Group 
The experimental group of male cardiac outpatients was recruited from a local 
cardiology practice. A sign posted at the reception window indicated the physicians' 
participation in the research study; this is provided in Appendix A. When patients 
arrived for a scheduled appointment with one of the cardiologists, prospective 
participants who met the sex and age criteria were informed that they were eligible to 
take part in the research study by office staff. A trained office staff member approached 
those who expressed an interest in participation. Training of the office staff member 
included the use of a script that is provided in Appendix A. Office staff members who 
collected data were required to abide by all rules of confidentiality and to provide their 
signatures to attest to that fact (form provided in Appendix B). Eligible participants 
were told in general what the study was about (examination of the relation of emotions 
and health conditions), that study participation was voluntary, that they could choose not 
to participate or to discontinue participation at any time without consequence, and that all 
information would be kept anonymous (no identifying information was collected). The 
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participants were also informed that the Introduction/Participation Solicitation letter 
provided two local mental health referral telephone numbers in the unlikely event 
someone might become upset as a result of answering the questions. They were also 
provided with the telephone number of the principal investigators, Dr. Robert A. 
DiTomasso, Ph.D., A.B.P.P., and told they had permission to contact him. They were 
informed that they could contact the researcher via e-mail (provided on the form) ifthey 
desired an abstract detailing the results of the study. 
If participants agreed to take pa1i in the study they were given 1. the 
IntToduction/Participation Solicitation letter, 2. the demographic sheet, 3. STAXI-2, and 
4. MAD-AS. Signed letters of authorization for use of the MAD-AS, obtained from the 
authors, are provided in Appendix B. The STAXI-2 materials (provided in Appendix A) 
were purchased through Psychological Assessment Resources (PAR) who owns the 
copyright for the test. Participants were encouraged to complete the protocols before they 
left the office; however, those who were not able to complete the material and needed to 
take it home were given an addressed, postage paid, white envelope to return to the 
researcher via mail. 
One third of the participants were given a retest packet in addition to the packet 
they were to fill out in the office. This packet contained the Introduction/Participation 
Solicitation letter (to reiterate confidentiality and voluntary status), the STAXI-2 and the 
MAD-AS and the participants were directed to fill out the materials one week later. The 
retest packets contained a $5 phone card as incentive to complete the forms and mail 
them back in the manila addressed, postage paid envelope as requested. The white and 
Anger and CRD 38 
manila colors were utilized as a color-coding method to diHerentiate the single test 
packets from the retest packets. The order in which the STAXI-2 and MAD-AS were 
presented in the packet was counterbalanced because in both groups and in all retest 
packets, half of the packets presented the STAXI-2 as the first instrument to complete 
whereas the other half were presented with the MAD-AS the first instrument to complete. 
Control Group 
The control group consisted of non-cardiac participants recruited from a private 
dental practice. The general demographic profile of the two geographic areas of the 
practices were found to be similar in total population, age, sex, racial composition, 
educational attainment, occupation, and SES, according to the 2000 Census data. A sign 
indicating notice of participation was posted at the reception window. A trained office 
staff member approached patients who were eligible to participate in the study. The 
office staff training and all other procedures were the same in both research groups. 
When all the data was collected, the infoIDlation was entered into an SPSS 
database Version 11.0 for Windows for statistical analysis. The data was independently 
entered and verified by the researcher. 
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Research Design and Statistical Analysis 
To assess the psychometric properties of the MAD-AS, this study employed 
conelational research design; it also used between groups analysis where it was relevant. 
The following psychometric analyses were conducted; 1) descriptive statistics on 
demographic data including means and standard deviations, 2) factor analysis with 
orothogonal varimax rotation of the MAD-AS, 3) Pearson R correlational analysis 
between the MAD-AS and STAXI-2 total scores, 4) co-efficient alpha reliability of the 
MAD-AS for total and subscales, 5) Pearson R correlational analysis of the MAD-AS and 
STAXI-2 subscale scores, 6) Multivariate analysis of variance (MANOVA) on the MAD-
AS total scores and STAXI-2 total and trait anger scores by group, 7) MANOVA on 
MAD-AS subscale scores by group, 8) test-retest reliability coefficients computed by 
Pearson R correlational analysis. Significance level for this study was set at .05. 
Chapter 3 
Results 
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Several analyses were conductcd to examine each of the seven research 
hypotheses utilizing a statistical significance level of .05. The descriptive statistics are 
reported first and include demographic information regarding age; subsequently, mcans 
and standard deviations are reported. Demographic information on marital status and 
CHD risk factors by group is then provided. To obtain a clear overall picture ofthe 
characteristics of each group and because previous research has found differences for 
various factors such as age (Spielberger, 1999), Chi Square tests were conducted on the 
demographic information to ascertain the presence of group differences. These 
differences are reported. A factor analysis with orothogonal varimax rotation was then 
conducted on the MAD-AS scores to determine which factors converged to create the 
subscales. To ascertain criterion validity of the MAD-AS, Pearson R correlational 
analysis between MAD-AS total scores and STAXI-2 total scores was conducted. To 
ascertain internal consistency of the MAD-AS, co-efficient alpha reliability of the total 
and subscales was conducted. To examine criterion validity of the MAD-AS further, 
Pearson R correlational analysis of the subscale scores of the MAD-AS and STAXI-2 
was conducted. Then group differences in anger scores were examined by conducting 
multivariate analysis of variance (MANOVA) on the STAXI-2 and MAD-AS total scores 
and trait anger scores by group. To obtain more information on group differences in 
anger, a MAN OVA on the MAD-AS subscale scores by group was conducted. Finally, 
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to ascertain test-retest reliability of the MAD-AS, test-retest reliability coefficients 
computed by Pearson R correlational analysis was conducted. 
Descriptive Statistics 
The Statistical Program for the Social Sciences, version 11.0 for Windows was 
utilized to create the database for this study. All data were independently entered and 
verified by the researcher. Verification consisted of the researeher's double- checking 
data entry for each response for every protocol and retest. 
A total of 300 male pmiicipants between the ages of 35 - 63 chose to take part in 
this study, 150 in the experimental cardiac group and 150 in the non-cardiac control 
group. Professions in which the men worked included but were not limited to mechanics, 
welders, teachers, firefighters, managerial workers, attorneys, priests, retired persons, 
disabled persons, supervisors, and healthcare workers. Protocols were not used ifthe 
pmiicipant did not meet inclusion criteria for age, sex, and health status. 
Age. The mean age for both groups combined was 50.35. The mean age wa'l 
47.49 for the non-cardiac group and 53.21 for the cardiac group. Table 1 provides 
statistics on means and standard deviation by group. Group age differences were 
observed, thus, a t test was conducted to confirm statistical significance. This test found 
signHicant differences (t = 65.863,p < .001). 
Table 1 
Age Statistics by Group 
Mean 
SD 
Non-Cardiac 
47.49 
8.45 
Cardiac 
53.21 
8.23 
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Marital status. Of the participants in the non-cardiac group; one hundred and 
eighteen (78.7%) were man-ied, sixteen (10.7%) were single, nine (6.0%) were divorced, 
four (2.7%) were cohabitating, three (2.0%) were separated, and none was widowed. Of 
the participants in the cardiac group; eleven (7.3%) were single, one hundred and twelve 
(74.7%) were married, five (3.3%) were separated, eighteen (12.0%) were divorced, two 
(1.3%) were widowed, and two (1.3%) were co-habitating. The majority of participants 
in both groups reported that they were married (non-cardiac = 78.7%; cardiac = 74.7%). 
The cardiac group differed because they reported double the divorce rate of the non-
cardiac group (non-cardiac = 6%, vs. cardiac = 12%); however, Chi Square analysis 
revealed that there was no statistical significance between the groups (Chi Square = 
7.249,p> .05). A frequency distribution table of marital status by group is provided in 
Table 2. 
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Table 2 
Frequency Distribution by Group: Marital Status 
Non-Cardiac Cardiac 
Frequency Percent Frequency Percent 
Single 16 10.7% 11 7.3% 
Married 118 78.7% 112 74.7% 
Separated 3 2.0% 5 3.3% 
; 
Divorced 9 6.0% 18 12.0% ' 
Widowed 0 0.0% 2 1.3% 
Co-Habitating 4 2.7% 2 1.3% 
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Risk/actors in the non-cardiac group. Ofthe paJiicipants in the non-cardiac 
control group, none had reported a cardiac diagnosis because those who endorsed this 
item were not used in the study. The exclusions were made to establish further the 
integrity of the control group because the study was examining those with confirmed 
heart disease in the experimental group in contrast to the control group who reported no 
heart disease. The majority, one hundred and thirty- eight (92.0%), reported that they did 
not have diabetes. Similarly, the majority, one hundred and eleven participants (75.0%) 
reported that they did not have hypertension. Three did not respond to this item. Of the 
thirty-six who reported that they did have hypertension, twenty-five were currently taking 
medication for the condition, eight were not, and three did not answer the question. 
The majority of participants, one hundred and twelve (76.0%), reported that they 
did not have high cholesterol. Two did not respond to the item. Of those with high 
cholesterol, four (2.7%) reported a cholesterol level ofless than 200, twenty-six (17.3%) . 
reported cholesterol levels between 200 - 239, and eight (5.3%) reported cholesterol 
levels over 240. 
One hundred and twenty participants (80.0%) reported that they did not smoke. 
Of those who did smoke, fifteen (10.0%) reported that they smoked less than a pack per 
day, and fifteen (10.0%) reported that they smoked more than a pack per day. 
The majority of participants, ninety-six (64%), reported that they exercised. Of 
those who did exercise, fifty-one (34.0%) reported their exercise to be moderate and 
thirty-nine (26.0%) reported their exercise to be vigorous. 
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Eighty-one (54.0%) participants reported that they were overweight. Of those 
who reported they were overweight, forty-two (28.0%) reported they were less than 20lbs 
overweight, twenty-four (16.0%) reported they were 20 - 30 lbs overweight, and fifteen 
(10.0%) reported they were over 30 lbs overweight. 
Only two, (1.3%), paIiicipants repOlied that they were currently in psychological 
counseling. Six (4.0%) reported that they were on antidepressants, five (3.3%) reported 
that they were on anti-anxiety medication. 
Risk/actors in the cardiac group. Of the participants in the cardiac group, all had 
a diagnosis of a heart condition because cardiac diagnosis was a criterion for inclusion in 
the study. As previously discussed, exclusion and inclusion criteria was set to establish 
the integrity of the groups because the study was examining those with confirmed heart 
disease in the experimental group in contrast to the control group who reported no heart 
disease. Of these cardiac patients, the majority, one hundred and fifteen (76.7%), 
reported that they were on multiple medications for the condition. Of those taking 
medications for a heart condition, fourteen (9.3%) were on aspirin therapy alone, nine 
(6.0%) were taking beta-blockers alone, two (1.3%) were taking Ace inhibitors alone, one 
(0.7%) was taking a calcium channel blocker alone, and one (0.7%) was on a diuretic 
alone. 
One hundred and seventeen (78.0%) participants reported that they did not have 
diabetes. However, the majority in this cardiac group, eighty-three (55.3%), reported that 
Anger and CHD 46 
they did have hypertension. One did not respond to this item. Of those with 
hypertension, sixty-eight (45.3%) were taking medications and eight (5.3%) were not. 
The majority of the cardiac group group, eighty-one (54.0%), rep0l1ed that they 
did have high cholesterol. Five did not respond to this item. Of those with high 
cholesterol, forty-seven (31.3%) rep0l1ed cholesterol levels under 200, twenty-six (17.3) 
reported cholesterol levels between 200 - 239, and thirteen (8.7%) reported cholesterol 
levels over 240. 
One hundred and twenty seven (84.7%), the majority of the cardiac group, 
reported that they did not smoke. Of those who did smoke, one hundred and twenty-
seven (84.7%) smoked less than a pack a day and twenty-three (15.3%) smoked more 
than a pack a day. Ninety-seven (64.7%) reported that they exercised. Of those who 
reported that they exercised, sixty-seven (44.7%) reported moderate activity, twenty-
seven (18.0%) reported vigorous activity. 
The majority in the cardiac group, ninety-nine (66.0%), reported to be 
overweight. One did not respond to this item. Ofthose who reported they were 
ovelweight, thirty-six (24%) were Jess than 20lbs overweight, twenty-eight (18.7%) were 
20 - 30 Ibs. overweight and thirty-four (22.7%) were more than 30lbs overweight. 
Four (2.7%) pal1icipants in the cardiac group reported that they were currently 
receiving psychological counseling. Twenty-one (14.0%) reported they were on 
antidepressant medication, and twenty (13.3%) reported they were on anti-anxiety 
medication. The preceding information for both groups is provided in Table 3. 
Anger and CHD 47 
The majority of cardiac patients, ninety-seven (64.7%), reported that they had a 
family history of heart disease but forty-nine (32.7%) did not; four did not respond to this 
item. 
Group differences in risk/actor profiles. To obtain a clear overall picture of the 
health profile of each group, Chi Square tests were conducted on the risk factors to 
ascertain the presence of group differences. Risk factors that were found to have 
significant group differences were: diabetes (Chi Square = 11.529,p < .001), 
hypertension (Chi Square= 29.992, p < .001), cholesterol (Chi Square= 30.371, p < .001), 
total cholesterol level (Chi Square = 22.190, P < .001), amount of exercise (Chi Square = 
4.266,p < .05), overweight (Chi Square = 4.546,p < .05), amount overweight (Chi 
Square = 6.581,p < .05), antidepressant medication use (Chi Square = 9.051,p < .05), 
and anti-anxiety medication use (Chi Square = 1O.162,p < .001). These findings indicate 
that the cardiac group were individuals with significantly more health problems than the 
non-cardiac group. 
Risk factors that did not reveal significant findings upon Chi Square analysis 
were: hypertension medication use (Chi Square = 3,456,p > .05), smoking (Chi Square = 
1.123,p> .05), amount smoked (Chi Square = 2.342,p > .05), exercise (Chi Square = 
.040, P > .05), and psychological counseling (Chi Square = .694, P > .05). Table 4 
provides this information. 
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Table 3 
Frequency Distribution by Group: CHD Risk Factors 
No Yes Supplemental Info 
Non- Diabetes 92.0% 8.0% 
C'9rilhw 
Hypertension 74.0% 24.0% Meds Yes = 16.7% 
i Meds No = 5.3% 
High Cho [esterol 74.7% 24.0% <200 =2.7% 
200-239 = 17.3% 
>240 = 5.3% 
Smoking 80.0% 20.0% < PaclvDay = 10.0% 
> Pack/Day = 10.0% 
Exercise 36.0% 64.0% Moderate _. 34.0% 
Vigorous = 26.0% 
Overweight 45.3% 54.0% < 20lbs = 28.0% 
20-301bs = 16.0% 
>30 = 10.0% i 
Counseling 97.3% 1.3% 
Antidepressant 95.3% 4.0% 
Anti-anxiety 96.7% 3.3% 
Cardiac Diabetes 78.0% 22.0% 
Hypertension 44.0% 55,3% Meds Yes = 45.3% 
Meds No = 5.3% 
High Cholesterol 42.7% 54.0% <200 - 31.3% 
200-239 = ]7.3% 
>240 = 8.7% 
~llloklllg ti4.7'7"0 D.3% < packluay - lU.U'Yo 
> PacklDay = 4.0% 
Exercise 34.7% 64.7% Moderate - 44.7% 
Vigorous = 18.0% 
Overweight 33.3% 66.0% <201bs = 24.0% 
20-301bs = 18.7% 
> 30lbs = 22.7% 
Counseling 95.3% 2.7'JIo 
Antidepressant 86.0% 14.0% 
Anti-anxiety 84.7% 13.3% 
Table 4 
Significant Group Differences: Risk Factors 
IUSKFACTOR 
Diabetes 
Hypertension 
Hypel1ension Medication Use 
High Cholesterol 
Total Cholesterol Level 
Smoking 
Amount Smoked 
Exercise 
Amount of Exercise 
Overweight 
Amount Overweight 
Psychological Counseling 
Antidepressant Medication Use 
Anti-anxiety Medication Use 
* Significant at the p < .05 level 
** Significant at the p < .001 level 
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CHI 
11.529** 
29.992** 
3.456 
30.371 ** 
22.190** 
1.123 
2.342 
.040 
4.266* 
4.546* 
6.581 * 
.694 
9.051 * 
10.162** 
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Factor Analysis of the MAD-AS 
A principal component, varimax rotated factor analysis using Eigenvalues greater 
than 1 was conducted. Six factors accounting for 51.08% of the variance were extracted. 
The factor loading criterion of~ .45 was utilized to detennine which items were retained 
on a given factor (see Table 6). 
Factor 1, Anger Resolution, comprised five items. These items measured 
difficulty getting over angry feelings "1 have trouble letting go of things that have 
angered me in the past", a need to get even, feeling bitter, experiencing thoughts of 
hurting others when angry, and holding grudges. Those who are high in this factor 
dimension have difficulty resuming baseline anger levels after an angry episode. 
Factor 2, Verbal Expression, was comprised of nine items. Hems include a 
tendency to be critical and argumentative "When people disagree with me, I argue" "1 am 
critical of others when angry", proneness to place blame on others for anger, overtly 
showing displeasure, and retaliatory behavior. Those who score high on this factor have 
a need to show and express anger and believe it is due to other external factors. 
Factor 3, Behavioral Dyscontrol, contained seven items. Those who score high in 
this factor have a tendency to experience anger more frequently "I anger more frequently 
than most people" often without reason "I get angry without reason", they throw objects 
when angry, they feel that they do not have control over anger, and they do not get over 
anger quickly, Those who score high on this subscale overtly display their anger, are 
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easily provoked to anger, and can become angry without a particular circumstance to 
precipitate the outburst. 
Factor 4, Physical Aggression, consisted of four items. These items tapped into 
the tendency to feel others intend to cause them anger "People intend to anger me" and 
they physically lash out at others "When provoked, I hit people". Those high on this 
scale tend to be more violent when angry. 
Factor 5, Physiological Arousal, contained 4 items. This scale captured the 
physiologic dimension of anger, which includes feelings of restlessness "When angry, I 
feel restless or agitated", muscle tension, rapid breathing, and rapid heart rate. Those high 
on this scale are more aware of the physical sensations related to the emotion of anger. 
Factor 6, Anger Justification, contained 3 items. These items describe the 
tendency to ruminate and let anger interfere with sleep "My anger keeps me up at night", 
and attribute anger to situational circumstances "When under stress, I get angry"; "In 
difficult situations, I get angry". Those who score high on this subscale have a tendency 
to expend a great deal of energy justifying explanatory causes oftheir anger. 
Descriptive statistics including means and standard deviations of tlle six subscales 
are provided in Table 5. 
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Table 5 
Subscale Descriptive Statistics 
MEAN STANDARD DEVIATION 
F1: Anger Resolution 4.30 2.82 
F2: Verbal Expression 7.80 3.67 
F3: Behavioral Dyscontrol 4.83 3.53 
F4: Physical Aggression 1.11 1.43 
: Physiological Arousal 3.85 2.57 
F6: Anger Justification 16 1.38 
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Table 6 
MAD-AS Factor Loadings of the Principle Components Val"imax Rotated Analysis 
"Factor 1: Anger Resolution 
Alpha = .82 Eigenvalue = 12.90 Variance = 29.99% Cumulative Variance = 29.99% 
Number [tern Factor Loading 
7. I have trouble letting go of things that have angered me in the past .747 
8. I hold grudges against those who have angered me .734 
3. I have trouble letting go of my anger .620 
1. I feel a need to get even with those who anger me .607 
33. I feel bitter about things .509 
19. When I am angry I have thoughts of hurting others .467 
Factor 2: Verbal Expression 
Alpha = .84 Eigenvalue =0 2.23 Variance = 5.18% Cumulative Variance = 35.18% 
Number Item Factor Loading 
27. When angry, I let it show .647 
30. T am argumentative .594 
23. The behavior of others causes me to get angry .529 
42. When someone offends me I retaliate .527 
14. I am critical of others when angry .514 
16. I blame others for my anger 
26. I insult people when r am angry 
32. When people disagree with me, I argue 
Factor 3: Behavioral Dyscontrol 
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.484 
.477 
.472 
Alpha =.74 Eigenvalue = 2.06 Variance 4.79% Cumulative Variance = 39.96% 
Number Item Factor 
11. I cannot control my anger .740 
5. I get angry without reason .567 
28. I lose control when angry .559 
6. I am quick to anger .519 
36. Once angry, I never get over it quickly .483 
10. I throw things when I am angry .472 
4. I anger more frequently than most people .449 
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Factor 4: Physical Aggression 
= 1.80 Variance = 4.20% Cumulative Variance 44.16% 
Number Item Factor Loading 
12. I hit those who anger me .797 
34. When provoked, I hit people .766 
20. People intend to anger me .582 
29. I threaten people when angry .545 
Factor 5: Physiological Arousal 
Alpha = .84 Eigenvalue = 1.53 Variance = 3.55% Cumulative Variance = 47.71% 
Number Item 
38. When angry, r feel my heart beating faster 
40. When angry, my breathing is rapid 
39. When angry, my muscles feel tense 
41. When angry, I feel restless or agitated 
Factor Loading 
.801 
.761 
.752 
.665 
Anger and CHD 56 
Factor 6: Anger Justification 
= 1.45 Variance = 3.37% Cumulative Variance 51.08% 
Number Item 
43. In difficult situations, I get angry 
35. When under stress, 1 get angry 
2. My anger keeps me up at night 
Correlations Between the A1AD-AS and STAXI-2 Total Scores 
Factor LdVU.U.cULC 
.604 
.465 
.450 
Correlational analysis was conducted between the MAD-AS and STAXI-2 total 
scores and was found to be statistically significant The Pearson Product Moment 
Correlation between total scores for the MAD-AS and STAXI-2 scales was .274 (p < .01) 
and is provided in Table 7. 
Table 7. 
Correlation between MAD-AS and STAXI-2 Total Scores 
MAD-AS TOTAL Pearson Correlation 
Sig. (I-tailed) 
N 
** Correlation is significant at the p < .01level (I-tailed). 
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STAXI -2 TOTAL 
.274** 
.000 
.255 
Coefficient Alpha Reliability o/the MAD-AS Total and Subscale Scores 
Internal consistency for the MAD-AS total scores and subscale scores was 
conducted using Chronbach's coefficient alpha reliability. Coefficient alpha for the 
entire scale was .93. Coefficient alpha for the subscale scores were as follows: Factor 1, 
.82; Factor 2, .84; Factor 3, .74; Factor 4, .72; Factor 5, .84; Factor 6, .68. Inter-
correlations of the MAD-AS subscales are provided in Table 8. 
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Table 8 
Pearson Inter-Correlations of the MAD-AS Factors 
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 
Factor] .667** .6] 9** .439** .46] ** .54] ** 
Factor 2 .684** .497** .504** .579** 
Factor 3 .479** .458** .58] ** 
Factor 4 .365** .335** 
Factor 5 .493** 
Factor 6 
Note: Significant atp < .001 level (one-tailed) 
Correlations Between the MAD-AS and STAXI-2 Subscale Scores 
Pearson R Product Moment Correlational Analysis was conducted between the 
MAD-AS and STAXlsubscales to examine the relationship between the scores. 
Correlations ranged from -.202 to .748 and were all significantly correlated with the 
exception F5 Physiological Arousal and SANGP State Anger- Physical. Table 9 provides 
the inter-correlations of these subscales. 
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Table 9 
Pearson Inter-Correlations Between MAD-AS and STAXI-2 Subscales 
STAXI-2 Subscales MAD-AS Subscales 
F 1 ANGRES • F2VERBAL F3BEHDYS F4P 
STATE Pearson Correlation 291** .263 ** .293** .219** .138** ,352** 
Sig. (I-tailed) .000 .000 .000 .000 .009 .000 
N 294 291 294 292 295 294 
• 
TRAIT Pearson Correiatio! .631 ** .703** .586** .596** .462** .491 ** 
Sig. (I-tailed) .DOO .000 .000 .000 .000 .000 
N 295 292 295 295 296 295 
SANGF Pearson CorreiuuUf: .241** .258** .286** .197** .164** .318** 
Sig. (l-taiJed) .000 .000 .000 .000 .002 .000 
N 297 294 297 295 19)( 19"' 
SANGV Pearson Correia .257** .221 ** .260** .198** .11.7** .316** 
( I-tailed) .000 .000 .000 .000 .022 .000 
N 298 295 298 296 299 298 
SANGP Pearson CorrellltiOI1 .285** .206** .223** .194** .080 .283** 
S ig. (Hailed) .000 .000 .000 .000 .083 .000 
N 297 294 297 295 298 297 
TANGT Pearson Corrcilltiol .513** .646** .748** ,363** .402** .476** 
Sig. (I-tailed) ,000 .000 .000 .000 .000 .000 
N 297 294 297 295 298 297 
T ANGR Pearson CorrelatiOi .470** .578** .425** .216** .3 70** .395** 
Sig. (I-tailed) .000 .000 .000 .000 .000 .000 
N 297 295 297 295 298 297 
AXO Pearson Correlation .475** .600"''' .579** .445** .355** .339** 
• Sig. (I-tailed) .000 .000 .000 .000 .000 .000 
N 295 292 ')95 293 2% 2~ 
AXI Pearson CorrelatioIl .580** .452** .422** .275** .409** .434** 
Sig. (I-tailed) .000 .000 .000 .000 .000 .000 
I N 287 285 287 285 288 287 
ACO Pearson Correlation -.411 ** -.476** -.640** -.392"'* -.272** -.377** 
Sig. (l-tailed) .000 .000 .000 .000 .O()() .000 
N 291 288 291 289 292 291 
ACI Pearson Correlation ·.410** -.423** -.534** -.367** -.202** -.344** 
Sig. (I-tailed) .000 .000 .000 .000 .000 .000 
N 292 290 292 290 293 292 
AXJlND Pearson Correlation .604** .625** .723"" .484** .396** .488** 
Sig. (I-tailed .000 .000 .000 .000 .000 .000 
N 273 271 273 27J 274 273 
** CorrelatIOns SIgnificant at p < .001 (I-tailed) 
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Group Dtfferences between MAD-AS Total Scores and STAXI-2 Total and Trait Anger 
Scores 
A multivariate analysis of variance (MANOVA) was conducted on the MAD-AS 
total scores and STAXI-2 total and trait anger scores to determine ifthere were 
significant differences between the cardiac and non-cardiac groups. The research 
hypothesis was that scores would be higher in total anger scores on the MAD-AS and 
STAXI-2 and trait anger on the STAXI-2 in particular. This test revealed non-significant 
findings, Wilks Lambda = .988, F (3,251) = l.002,p > .05, indicating no overall 
differences between the groups. However, based on detection of age effects in anger 
(Spielberger, 1999), a MANCOVA using age as a covariate was conducted. This test 
revealed significant findings, Wilks Lambda = .965, F (3,250) = 3.034,p < .05. It was 
found that the MAD-AS total scores were significant, F = 6,427,p < .05, and STAXI-2 
total scores, F = 1.225,p > .05 and STAXI-2 trait anger scores F = 1.348,p > .05 were 
not significant. 
The findings regarding age initiated the prospect that the MAD-AS may also be 
proficient enough to detect differences if significant demographic variables were 
controlled for. To test this hypothesis, the significant variables had to be established by 
conducting Chi Square analysis on reported demographic factors. Significant factors that 
were identified were hypertension, diabetes, overweight, cholesterol, antidepressant use, 
and anti-anxiety medication use. A MANCOV A was conducted using these factors as 
covariates. The underlying assumption was that if these factors were controlled for, 
Anger and CHD 61 
group differences might be detected. This test was found to be significant, Wilks 
Lambda = .926, F (2, 83) = 3.301,p < .05. Hence, when hypertension, diabetes, 
overweight, cholesterol, antidepressant use, and anti-anxiety medication use were 
controlled for, the cardiac group had significantly higher levels of anger than the non-
cardiac group as measured by the MAD-AS, F == 6.656,p < .05, but not for the STAXI-2, 
F = .050, P > .05. 
Group Differences between MAD-AS Subscale Scores 
A multivariate analysis of variance (MANOVA) was conducted on the MAD-AS 
subscale scores in the cardiac and non-cardiac groups to determine ifthere were 
differences. The research hypothesis was that the cardiac group would score higher on 
the MAD-AS subscales than would the non-cardiac group. This test revealed non-
significant results, Wilks Lambda = .968, F (6, 283) = 1.545,p > .05. Again, because age 
effects in anger have been reported (Spielberger, 1999), a multivariate analysis of 
covariance (MANCOVA) was conducted using age as a covariate. This test was 
significant, Wilks Lambda = .943, F (6,282) = 2.839,p < .05. Significant subscales that 
were observed were: F2 Verbal ExpressionF = 3.942;p < .05; F3 Behavioral Dyscontrol 
F = 6.021, p < .05; and F4 Physical Aggression F = 10.188, p < .05. 
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Test-Retest Reliability of MAD-AS 
Test-retest reliability refers to an instrument's stability over time; therefore, 
scores from one administration of a measure at a pa11icular point in time should 
significantly correlate with scores from the same instrument at another point in time if the 
measure is reliable. This study used a one- week period of elapsed time between 
administrations from the first period to the retest period. Of the 300 participants in the 
study, one-third (100) were given a retest. Sixty-five participants completed and retumed 
the retests. MAD-AS total score test-retest reliability coefficients was computed using 
Pearson R correlational analysis was .87 (p < .01, one-tailed) and is provided in Table 10. 
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Table 10 
Test-Retest Correlational Analysis 
RMADASTOT 
MADASTOT Pearson Correlation .872** 
Sig. (I-tailed) .000 
N 62 
** Correlation is significant at the p < .01 I.evel (I-tailed). 
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Chapter 4 
Discussion 
This is the fourth study that examined the MAD-AS as a psychometrically sound 
instrument measuring self-reported anger; it the first study to do so in an outpatient 
cardiac population. The first study (Mahan, 2001) found strong psychometric properties 
that appear to measure successfully the cognitive, physical, and behavioral aspects of 
anger. The second study (Martin, 2002) found a similar factor structure and introduced 
a Significant Other (SO MAD-AS) version ofthc instrument. The third study 
(Beardmore, 2003) again observed a similar and significant factor structure of the MAD-
AS in an outpatient population. The present study is able to lend further credibility to the 
psychometric soundness of the MAD-AS by observing again a similar factor structure, as 
well as strong reliability and validity. This research makes an important contribution to 
the study of anger because the MAD-AS is a proving to be a robust anger measure that 
takes less time than other measures. As such, the original goal of the Mahan (2001) 
study, which was to introduce the MAD-AS as a screening tool similar to the Beck 
inventories, may be realized. 
Descriptive Statistics 
Age statistics. Normative data for the ST AXI-2 is based on 1,900 hospitalized 
psychiatric patients (N = 276; 105 females, 171 males) and non-psychiatric patient adults 
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(N = 1,644; 977 females, 667 males). The mean age of the normal adult sample is 
approximately 27 years and the age range is from 16 to 63. Of the 1,900 normed STAXI-
2 subjects, 838 were males. Of that male sample, 667 were normal adults as contrasted to 
psychiatric patients. Ofthe 667 non-psychiatric males, only129 were 30 years old and 
older. Hence, for the purposes of the CUlTent study, the comparison group from the 
STAXI-2 is composed of 129 subjects. The current study looked specifically at 300 male 
participants in the 35-63 year old age range, which is a significant issue given that the 
average age for a male's having a first MI is 65.8 (AHA, 2004). Indeed, the current study 
found statistically significant differences because the non-cardiac group was composed of 
younger, healthier men and the men in the cardiac group were older less healthy!. 
Risk/actors. A significant difference was observed between the cardiac group 
and the non-cardiac group regarding risk factors. An examination of health profiles 
denotes two groups with distinct characteristics. The cardiac group reported a 
significantly higher rate of diabetes, hypertension, high cholesterol, and overweight status 
as compared with the non-cardiac group. Thus, the cardiac group demonstrated the 
presence of many risk factors related to CHD. This supports the fact that conventional 
risk factors are highly associated with CHD and must be modified to benefit health status. 
However, it was an interesting finding that hypertension medication use between both 
groups was not significant. This implies the fact that of those participants who have 
hypertension, similar ratios take medications to control it regardless of group status. 
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Smoking status and amount smoked was not significantly different between 
groups. Tn fact, more participants in the non-cardiac group smoked, and smoked greater 
amounts (greater than 1 pack per day). This is a finding that makes sense if one considers 
the health status circumstances of each group. The non-cardiac group comprised younger 
men who do not have any significant medical diagnosis; therefore, they are exposed to 
the same amount of anti-smoking messages as most Americans via media, family, and 
friends. As such, the mcYority of the group does not smoke; however, those who do 
smoke have not had any harsh health consequence from the habit to strongly dissuade 
tobacco use. On the other hand, the cardiac group is in treatment for a major medical 
condition that is directly related to tobacco use. There is a great likelihood that these 
participants have been told by several healthcare providers that they must stop smoking 
because it has contributed to their CHD. They most likely have family members that 
have done their best to help improve overall health habits and discourage smoking. 
These participants had a rather substantial scare and many have taken the scare seriously 
and accordingly have abstained from tobacco. 
Another finding that is of note is that exercise habits were not significant between 
the groups; however, the amount of exercise in which one engaged was significant. The 
fact that over 64% of all participants reported that they got exercise is encouraging given 
that approximately 55% of Americans do not exercise (AHA, 2004). Again, these 
findings logically follow if one considers the circumstances of the participants. For 
instance, more cardiac participants may be exercising now because of the CHD diagnosis 
and promptings by healthcare professionals. They may be involved in cardiac 
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rehabilitation, a supervised exercise program particularly designed for cardiac patients. 
This would coincide with the finding that the cardiac group exercised more moderately 
(activities such as walking or bicycling lasting at least 30 minutes on 5 or more of7 days) 
as opposed to more vigorously (activity causing hard breathing and sweating for at least 
20 minutes on 3 or more of7 days). Conversely more non-cardiac participants exercised 
more vigorously than moderately. Age may also playa role in amount of exercise 
because the non-cardiac group is a younger group. Also, if many exercisers in the 
cardiac group did not get exercise before their diagnosis but are doing so now in response 
to a health threat, they may be more apt to do the minimum (moderate) amount required. 
An older man in his 50's who begins an exercise program for the first time in many years 
will most likely lack the exercise capacity of a younger man in his 30's who has been 
exercising throughout his life. 
Fear may also playa role in cardiac patients' willingness to engage in vigorous 
exertion. Many of the physiological sensations that can be a result of vigorous exercise 
(sweating, lightheadedness, chest discomfort) are similar to the symptoms of a heart 
attack. It may be difficult for many of the cardiac participants to push themselves to the 
vigorous level for fear that pushing too far may initiate an MI. Certainly, a similar 
thought process plays a role in the retum to sexual intimacy (Moser & Dracup, 1995) 
because the patient does not retum to pre-MI sexual frequency (Hamilton & Seidman). 
It was found that the cardiac group reported significantly more antidepressant and 
anti-anxiety medication use. It is logical to surmise that dealing with a major medical 
condition places enough stressors on one to initiate the use of medication. More contact 
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with medical professionals may also give rise to more opportunity to discuss problems, 
thus, the cardiac group may simply have had more occasion to address overall 
functioning than the non-cardiac group. In our managed care environment, addressing 
only significant medical issues is more of the norm than a long discussion of the patient's 
mental state in an office visit. It could also be argued that those who have psychological 
issues prompting one to engage in unhealthy behaviors that result in CHD are more likely 
to use psychotropic medication. This "catch-22"has been an issue in the assessment of 
psychological correlates of CHD, resulting in inconsistent findings. 
Construct Validity 
Construct validity is the extent to which an instrument accurately measures a 
particular construct (Kazdin, 1992), in this case anger. The factor analysis of the MAD-
AS in the present study supports its construct validity, following a similar pattern as 
previous research examining the instrument (Beardmore, 2003, Mahan, 2001, & Martin, 
2002). The factor analysis in this study revealed 6 subscales: anger resolution, verbal 
expression, behavioral dyscontrol, physical aggression, physiological arousal, and anger 
justification. The original Mahan study (2001) identified seven subscales: anger 
dyscontrol, angry cognitions, verbal expressions of anger, physiological arousal, anger 
justificationlblame, externalization of anger, and difficulty with anger resolution. The 
Martin (2002) study identified six subscales: difficulty with anger resolution, emotional 
dycontTol, physiological arousal, physical anger/aggression, argumentativeness, and 
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display of anger. Finally, Beardmore (2003) found six subscales: behavioral dyscontrol, 
anger resolution, aggression, physiological arousal, extemalization of anger, and verbal 
expression of anger. 
All four studies contain a physiological arousal subscale and an anger resolution 
subscale. An four studies contain a sub scale consisting of anger expressed vocaUy: 
Mahan - Verbal expressions of anger; Martin -Argumentativeness; Beardmore - Verbal 
expressions of anger; Current study - Verbal expression. All four studies found a 
subscale that addresses anger out of control: Mahan - Behavioral dyscontrol; Martin-
Emotional dyscontrol; Beardmore - Behavioral dyscontrol; Current study - Behavioral 
dyscontrol. All studies found a subscale that addresses physical aggression: Mahan-
Behavioral dyscontrol; Martin - Physical anger/aggression; Beardmore - Aggression; 
Current study - Physical aggression. Three of the four studies found a scale that is 
composed of outward blame for anger: Mahan - Anger justificationlblame; Beardmore-
Extemalization of anger; Current study - Anger justification. Hence, it is clear that all 
four MAD-AS studies have followed a similar factor structure. 
Construct validity also refers to the extent to which an instrument measures what 
it claims to measure, in this case anger. One way to establish construct validity is to 
measure its relatedness to another established measure of the same construct (Gravetter & 
WaIlnau,2000). In this study, the STAXI-2 was used to establish validity by comparing 
both total scores as well as sub scale scores of the measure with the MAD-AS. 
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Correlations between the MAD-AS and STAXI-2 total scores. The MAD-AS 
total scores significantly correlated with the STAXI-2 total scores. The Pearson Product 
Moment Correlation between total scores for the scales was .274, p < .01. However, 
because the correlation did not appear to be very strong, and age appeared to be a factor 
in scores, a partial correlation was conducted. Partial correlations involve partialling out, 
or controlling for, the effects of one or more variables (Howell, 1997). Age was utilized 
in this case as the variable controlled for. This test found a slightly higher correlation 
(.284, p < .01) but it was not dramatically higher. Thus, the correlation between MAD-
AS and STAXI-2 total scores moderately support the construct validity of the MAD-AS. 
Correlations between the MAD-AS and STAXI-2 subscales. Another measure of 
construct validity was the comparison of MAD-AS subscales with the STAXI-2 
subscales. All subscales ofthe MAD-AS and STAXI-2 had significant inter-correlations 
with the exception ofF5 Physiological Arousal and SI Ang-P (state anger- physical). The 
fact that these two subs cales did not correlate makes logical sense, given the fact that an 
individual who is not angry at the moment would not experience any physiological 
arousal. There were several strong eorrelations that were observed such as: T-Ang and 
F2 verbal; T-Ang and Fl anger resolution; T-Ang/T and F2 verbal; T-Ang/T and F3 
behavioral dyscontrol; and AX-O and F2 verbal expression. 
Trait anger is conceptualized as a more enduring mode of responding to situations 
in a similar manner, which includes heightened anger arousal. Individuals with high trait 
anger experience anger more often and with greater intensity than those with low trait 
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anger. The trait anger (1' -Ang) scaJes measure how often one experiences anger over a 
period oftime, thus the high correlation with the MAD-AS F2: verbal expression 
subscale is logical, given that the verbal subscale includes items that indicate an 
individual's propensity to be critical of others, to let anger show, to be insulting and 
argumentative and to believe that is others who are at fault for his or her anger. 
STAXI-2 trait anger and MAD-AS FI anger resolution significantly correlate, 
which is also a logical connection. Again, trait anger is conceptualized as a more 
enduring mode of responding to situations with heightened anger arousal. Thus, if 
someone experiences frequent and intense anger and has the propensity to attribute his or 
her anger to other's behavior (as correlated with F2 verbal expression), a significant 
correlation with FI anger resolution would be consistent. FI anger resolution deals with 
one's difficulty in letting go of anger, in holding grudges, in feeling a need to get even, 
and in feeling a desire to physically harm others when angry. Thus, if individuals often 
and intensely experiences anger that they believe is due to other people's behavior, they 
would have difficulty letting it go and returning to pre-anger status. They have felt the 
effects of something they do not believe is under their control so they are quite angry 
about it and are not so willing to let it go. 
STAXI-2 trait anger - temperament (T -Ang/T) measure one's tendency to 
become angry without provocation. This subscale significantly correlated with the 
MAD-AS F2 verbal expression subscale. As previously discussed, the F2 verbal 
expression subscale indicates an individual's propensity to be critical of others, to let 
anger show, to be insulting and argumentative and to believe that is others who are at 
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fault for his or her anger. These two scales correlate because an individual who has the 
tendency to fly ofTthe handle without being provoked would be liable have the tendency 
to blame others for the occurrence because it would help rationalize the anger reaction. 
Once more, the STAXI-2 trait anger - temperament (T-Ang/T) subscale 
measures one's tendency to become angry without provocation. The MAD-AS F3 
behavioral dyscontrol subscale measures one's propensity to be quick to anger frequently 
without reason and to throw things and feel a loss of control. It is reasonable to deduce 
that these subscales highly correlate for the reason that they both deal with intense, 
frequent, unprovoked periods of intense anger. 
Ibe STAXI-2 anger expression out subscale (AX-O) measures the preference to 
exhibit the expression of anger in a verbally or physically aggressive manner. As 
previously mentioned, the MAD-AS F2 verbal expression subscale indicates an 
individual's propensity to be critical of others, to let anger show, to be insulting and 
argumentative and to believe that is others who are at fault for his or her anger. 1bese 
scales correlate because they both address one's verbal and/or physical aggressiveness in 
anger expressIOn. 
Reliability 
Reliability generally refers to the consistency of a measure, which is an 
instrument's ability to produce stable, consistent measurements (Gravetter & Wallnau, 
2000). To assess the reliability of the MAD-AS, the intemal consistency as measured by 
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Chronbach's alpha and test-retest reliability as measured by Pearson R correlational 
analysis was calculated. 
Internal consistency. Internal consistency for the MAD-AS total scores and 
subscale scores was conducted using Chronbach's coefficient alpha reliability. 
Coefficient alpha for the entire scale was found to be a robust .93. Coefficient alpha for 
the MAD-AS subscale scores were also strong and are as follows: Factor 1, .82; Factor 2, 
.84; Factor 3, .74; Factor 4, .72; Factor 5, .84; Factor 6, .68. Thus, this study supports the 
notion that the MAD-AS does, in fact, measure the anger constructs that it was developed 
to measure. 
Test-retest reliability of MAD-AS. Test-retest reliability refers to an instrument's 
stability over time; therefore, scores from one administration of a measure at a particular 
point in time should significantly correlate with scores from the same instrument at 
another point in time ifthe measure is reliable. This speaks to the measure's consistency. 
This study used a one- week period of elapsed time between administrations. Ofthe 300 
participants in the study, one-third (100) were given a retest. Sixty-five participants 
completed and returned the retests. MAD-AS total score test-retest reliability coefficients 
were computed using Pearson R cOlTelational analysis. Test retest reliability was found 
to be .87, demonstrating strong temporal stability. For comparison sake, the STAXl-2 
reported test-retest reliability as .88. 
Anger and CHD 74 
Group Differences Between MAD-AS Total Scores and STAXI-2 Total and Trait Anger 
Scores 
A multivariate analysis of variance (MAN OVA) was conducted on the MAD-AS 
total scores and STAXI-2 total and trait anger scores to determine if there were 
significant differences between the cardiac and non-cardiac groups. The research 
hypothesis was that scores would be higher in total anger scores on the MAD-AS and 
STAXI-2 and trait anger on the STAXI-2 trait anger subscale in particular. This test 
revealed non-significant findings, Wilks Lambda = .988, F (3,251) = 1.002,p > .05, 
indicating no overall differences between the groups. However, based on detection of 
age effects in anger (Spielberger, 1999), a MANCOV A using age as a covariate was 
conducted. This test revealed significant findings, Wilks Lambda = .965, F (3,250) = 
3.034,p < .05. It was found that the MAD-AS total scores were significant, F = 6.427, p 
< .05, and the STAXI-2 total scores, F = 1.225,p > .05 and STAXI-2 trait anger scores F 
= 1.348,p > .05 were not significant. This finding is unexpected because the MAD-AS 
appears to be uncovering some aspect of anger masked by age. 
The findings regarding age initiated the prospect that the MAD-AS may also be 
proficient enough to detect differences if significant demographic variables were 
controlled for. To test this hypothesis, the significant variables were derived by 
conducting Chi Square analysis on reported demographic factors. Significant factors 
that were identified were hypertension, diabetes, overweight, cholesterol, antidepressant 
use, and anti-anxiety medication use. A MANCOV A was conducted using these factors 
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as covariates. The underlying assumption was that if these factors were controlled for, 
group differences might be detected. This test was found to be significant Wilks Lambda 
= .926, F (2, 83) = 3.301, p < .05. Hence, when hypertension, diabetes, overweight, 
cholesterol, antidepressant use, and anti-anxiety medication use were controlled for, the 
cardiac group had significantly higher levels of anger than the non-cardiac group as 
measured by the MAD-AS, F = 6.656, p < .05, but not the STAXI-2, F = .050, P > .05. 
These findings support the concept that anger may indeed playa role in CRD, 
highlighting the notion that future investigations may benefit from a research design that 
matches subjects for age and risk factors to get a more accurate picture in the anger/CHD 
connection. 
Group Differences Between MAD-AS Subscale Scores 
A multivariate analysis of variance (MANOVA) was conducted on the MAD-AS 
subscale scores in the cardiac and non-cardiac groups to detennine if there were 
differences. The research hypothesis was that the cardiac group would score higher on 
the MAD-AS subscales than would the non-cardiac group. This test revealed non-
significant results, Wilks Lambda = .968, F (6, 283) = 1.545, p > .05. Again, because age 
effects in anger have been reported (Spielberger, 1999), a multivariate analysis of 
covariance (MANCOVA) was conducted using age as a covariate. This test was 
significant, Wilks Lambda = .943, F (6,282) = 2.839, p < .05. Significant subscales that 
were observed were: F2 Verbal Expression F = 3.942; p < .05; F3 Behavioral Dyscontrol 
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F = 6.021, p < .05; and F4 Physical Aggression F = 10.188, p < .05. Thus, it would 
appear that men who have difficulty with more explosive forms of anger (e.g. "1 insult 
people when I am angry", "1 throw things when I am angry", "1 lose control when 1 am 
angry", "When provoked, 1 hit people") have more incidence of CHD when age is 
controlled for. These findings are consistent with the findings of the Onset Study 
(Mittleman, et aI., 1995) and the Sheep Study (Moller, Hallqvist, Diderichsen, Theorell, 
Reuterwall, & Ahlborn, 1999) because intense anger episodes were found to be capable 
of triggering a cardiac event. 
Treatment Implications 
Mahan (2001) described his rationale for developing the MAD-AS as "the need to 
create a relatively brief, clinically sensitive, screening instrument for use by cognitive-
behavioral therapists interested in the treatment of anger not only for assessing anger but 
also for measuring treatment outcome." This is an important contribution to the field 
because anger difficulty is implicated in every major facet of one's life. The potential 
utilization of this measure to track therapeutic pro gress would be similar to the use of the 
Beck inventories because of the brevity and strong psychometric properties of the MAD-
AS. Risk assessment and treatment planning could also be accomplished utilizing the 
MAD-As, given the descriptive data provided in the subscales. 
It is quite plausible that the medical community may benefit from utilization of 
the MAD-AS. Given that the American Heart Association added psychosocial evaluation 
and intervention into its Core Components of Cardiac Rehabilitation/Secondary 
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Prevention program (AHA, 2000), it appears logical that evaluation of one's level of 
anger is as important a measure as evaluation of one's level of stress. Once screening 
identifies an individual found to have difficulties with anger, tailored interventions could 
be implemented. The more complete and well-rounded the rehabilitation program, the 
better likelihood of successful recovery and improved health for countless Americans. 
The initiation of screenings and interventions for problematic anger after CHD 
has occurred is by all accounts a reactive approach, whereas more insurance providers are 
attempting to become more pro-active in health matters because this is a more fiscally 
sound approach. Promotion of wellness, of prevention, and of screening that prevents, 
detects or slows the progression of disease has grown recently (Scala-Foley, Caruso, 
Archer, & Reinhard, 2004). Accordingly, a new initiative for Medicare in 2005 is a one-
time physical wellness exam (al) cited in Scala-Foley, Caruso, Archer, & Reinhard, 
2004), which will include, among other things, early detection of CHD. This benefit 
reflects the shift from disease treatment to disease prevention with the recognition of 
biopsychosocial factors involved in disease processes. It is plausible that those found to 
be at high risk for CHD through wellness exams could undergo fUrther screening; this 
could include the MAD-AS in attempts to reduce modifiable risk factors. 
implications for Future Research 
There are several areas that would benefit from further investigation. First and 
foremost is the disparity in the experience and expression of anger between the older age 
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group and the younger participants. A betier understanding of how individuals 
experience and cope with anger as they age would establish a clearer picture ofthe 
relationship of anger to CHD and other health concerns. The sample of cardiac patients 
had a poorer health status than the nono-cardiac sample; however, it is unclear exactly 
what was responsible for this disparity. A study that matches subjects for traditional risk 
factors would lend a betier understanding of potential anger dimensions that accompany 
the CHD process. This may provide a valuable screening framework for a potential 
triage of cardiac patients to target at-risk individuals more successfully. 
Women were purposely excluded from this study to keep the highest degree of 
integrity of the anger construct among men entering the age at which CHD is most 
prevalent. The exclusion was necessitated by observed gender differences in anger 
experience and expression. For instance, Linden, Hogan, Rutledge, Chawala, Lenz, and 
Leung (2003) found that women used a wider range of coping strategies than men, 
especially anger diffusion strategies and social support seeking. This suggests that anger 
may playa different role in how women perceive, express, and are generally affected by 
anger. If women indeed seek social support more than men, does thi s equate to anger 
reduction or to reduced physiological impact of anger on the body? If so, is this a health-
protective factor? Research that examines these gender differences in anger would 
contribute greatly to the field. Furthermore, a recent study (Eaker, Sullivan, Kelly-
Hayes, D' Agostino, & Benjamin, 2004) found that after having controlled for traditional 
risk factors ofCHD, neither the psychosocial variables oftrait anger, TABP, nor hostility 
were related to CHD in women; however, trait anger was found to relate to total 
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mOliality in men. Future research that addresses these issues would be extremely 
beneficial to understanding and improving women's health. 
Limitations of the Study 
The major limitation of this study is its use of self-report measures. Inherent in 
self-report measures is the possibility that not all participants were fully accurate in their 
responses. The use of self-report instruments may be confounded by social desirability 
effects; this was found by Martin (2002) in a study that looked at self-report scores versus 
spouse's scores or significant others' scores. This study concluded that the self-reporters 
were significantly more apt to respond in a manner that was more socially desirable even 
when the individual would not necessarily act that way in a particular situation. 
Responses can also be affected by low self-awareness of one's own cognitive, behavioral, 
and affective responses to anger and hostility (Kneip, Delamater, Ismond, Milford, 
Salvia, & Schwartz, 1993) because of biases. 
Along with self-report limitation is the fact that although a person may be 
predisposed to react in a certain manner, that does not necessarily mean that he or she 
will always react that way in all situations. One low in trait anger may react to a stressful 
situation inconsistently. It also does not mean that individuals experience the same 
number of stressful situations; this creates a difficulty in predicting the rea] effect on 
CHD However, given even the limitations of studying anger and hostility and their 
Anger and CHD 80 
relationships to CHD through self-report measures, it is clear that there is a growing body 
of evidence that implicates anger in some aspect of CHD. 
Summary 
In summary, this study found psychometric support that the MAD-AS is a 
structurally durable and stable measurement ofthe cognitive, affective, and behavioral 
components of anger. The fact that this is the fourth study to come to the same 
conclusion bodes well for the instrument. This is a significant contribution to the field 
because this measurement less lengthy than other instruments and therefore estimated to 
be less costly. In our present managed-care environment, a time and cost conscious 
screening measure that is also psychometrically sound would prove quite useful. 
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Appendix A 
Dear PaI1icipant: 
We are doing a study on the relationship between feelings and medical problems. If you 
are a male between the ages of 35 and 63 and you have no other major medical illnesses 
other than a diagnosis of a heart ailment (such as cancer or organ failure) and can read 
and speak English, you may be eligible to be in the study. Your decision to be in this 
study is completely voluntary. You may decide not to participate or discontinue 
participation at any time. In no way will your health care be affected whether or not you 
choose to be in the study. All infOlmation will be kept strictly confidential. You will not 
be asked to provide your name on any material, therefore, no one will be able to identifY 
you. Your physician and health care workers will not have access to this information. 
Tfyou choose to be part of this study, you will be given a packet and asked to fill out 
three questionnaires that take about 20 minutes of your time. The first questionnaire asks 
about your age, sex, marital status, lifestyle, and health history. The other two 
questionnaires ask questions about your feelings. If your packet contains two sets of 
questionnaires, you are requested to fill out one packet now, and the one marked 
"RETEST" ONE WEEK later and place it in the postage paid envelope provided and 
mail it back to the researcher. There will be a number on each fonn that is used to match 
forms should pages get separated and to match mailed in retest packets. 
The questionnaires ask about your thoughts, feelings, and behaviors. It is possible that 
you may learn something about yourself of which you did not know before. In the 
unlikely event that you become uncomfortable or upset with your answers to any ofthese 
questions, please contact First Hospital Wyoming Valley at 1(800) 624-9902 if you are in 
Luzerne county or Scranton Counseling Center at 1(570) 348-6100 if you are in 
Lackawanna county for a mental health referral. You may even choose to contact the 
principal investigator, Robert A. DiToma.'lso, Ph.D., A.B.P.P. at (215) 871-6511. 
If you would like a summary ofthe results of this study, you may contact the co-
investigator, Kimberly D'Andrea, M.S. via e-mail at KimberlyDa.studpob.Stud. 
Thank you very much for your participation in this investigation. 
Kimberly S. D' Andrea, M.S. 
Philadelphia College of Osteopathic 
Medicine 
DepaItment of Psychology 
4190 City Avenue 
Philadelphia, P A 19131 
Robert A. DiTomasso, Ph.D., A.B.P.P. 
Professor and Vice Chair, Department of 
Psychology 
Philadelphia College of Osteopathic 
Medicine 
4190 City Avenue 
Philadelphia, Pa 19131 
Anger and CHD 93 
Appendix A 
Dear Participant: 
We are doing a study on the relationship between feelings and medical problems. If you 
are a male between the ages of35 and 63 and you have no m~or medical illnesses (such 
as cancer, heart disease, or organ failure), and can read and speak English, you may be 
able to be part ofthe study. Your decision to be in this study is completely voluntary. 
You may decide not to participate or discontinue participation at any time. In no way 
will your health care be affected whether or not you choose to be in the study. All 
information will be kept strictly confidential. You will not be asked to provide your 
name on any material, therefore, no one will be able to identify you. Your dentist and 
health care workers will not have access to this information. 
If you choose to participate, you will be given a packet and asked to fill out three 
questionnaires that take about 20 minutes of your time. The first questionnaire asks 
about your age, sex, marital status, lifestyle, and health history. The other two 
questionnaires ask questions about your feelings. If your packet contains two sets of 
questionnaires, you are requested to fill out one packet now, and the one marked 
"RETEST" ONE WEEK later and place it in the postage paid envelope provided and 
mail it back to the researcher. There will be a number on each form that is used to match 
forms should pages get separated and to match mailed in retest packets. 
The questionnaires ask about your thoughts, feelings, and behaviors. It is possible that 
you may learn something about yourself of which you did not know before. In the 
unlikely event that you become uncomfortable or upset with your answers to any of these 
questions, please contact First Hospital Wyoming Valley at 1 (800) 624-9902 if you are 
in Luzerne county or Scranton Counseling Center at 1 (570) 348-6100 if you are in 
Lackawanna county for a mental health referral. You may even choose to contact the 
principal investigator, Robert A DiTomasso, Ph.D., AB.P.P. at (215) 871-6511. If you 
would like a summary of the results of this study, you may contact the co-investigator, 
Kimberly D'Andrea, M.S. via e-mail at KimberlyDa.studpob.Stud. 
Thank you very much for your participation in this investigation. 
Kimberly S. D'Andrea, M.S. 
Philadelphia College of Osteopathic 
Medicine 
Department of Psychology 
4190 City Avenue 
Philadelphia, P A 19131 
Robert A DiTomasso, Ph.D., AB.P.P. 
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PLEASE COMPLETE EACH QUESTION BY FILLING OUT OR 
CHECKING THE APPROPRIATE ANSWER 
Age: 
Sex: Male Female 
.- .. _- '---
Marital Status: Single___ MaITied___ Separated __ _ 
Divorced __ ..... _ Widowed'--__ Co-Habitating, __ _ 
Cardiac History: 
4) Have you ever been diagnosed with a cardiac illness? Yes No 
5) Do you have a heart condition that you had since birth? Yes No __ _ 
6) If you are currently taking medication for a cardiac diagnosis, check the ones you take: 
___ calcium channel blockers (e.g.: Procardia/Nifedipine, Norvasc/Amlodipine, 
CalanlV erapimil) 
___ ,ACE inhibitors (e.g. CapoteniCaptopril, VasotecfEnaiapril, 
PriniviVLisinopril, AltacefRamipril) 
___ b. eta-blockers (e.g. Metaprolol/LopressoriToprol, A tieno 10 I/Tenormin, 
Propranololllnderal) 
___ diuretics (water pill) 
___ aspirin 
General Medical History: 
7) Do you have diabetes? Yes No __ _ 
8) Do you have high blood pressure? Yes No __ _ 
9) If yes, are you taking medication to lower it? (e.g. Cozaar/Losartan, DiovanlValsartan, 
Avapro/Irbpsartan, AtacandiCandesaI1an) Yes No __ _ 
10) Do you have high cholesterol? Yes No ___ _ 
11) If yes, what is your total cholesterol level? Less than 200 200 .~ 239 __ _ 
12) 
13) 
14) 
15) 
16) 
17) 
18) 
19) 
20) 
21) 
22) 
23) 
Above 240 __ _ 
Do you smoke? Yes No __ _ 
If yes, how much? Less than 1 pack per day More than 1 pack a day ___ _ 
Do you exercise? Yes __ _ 
If yes, is it vigorous or moderate? 
__ ._._ Vigorous (activity causing hard breathing 
and sweating for at least 20 minutes on 3 or more of7 days) 
____ Moderate (activities such as walking or bicycling lasting at least 30 minutes on 5 or 
more of7 days) 
Are you overweight? Yes No __ _ 
If yes, how much? 10-201bs 20-30lbs Over 30 Ibs_._ .. __ ._ 
Do you have a family history of heart disease? Yes No __ _ 
Are you currently receiving psychological counseling? Yes No __ --:-
Are you currently taking antidepressant medication? (e.g.: Prozac, Zoloft, Paxil, Wellbutrin) 
Yes No __ _ 
Are you currently taking antianxiety medication? (e.g.: Xanax, Valium, Ativan) 
Do you have any major illnesses? (cancer, organ failure) 
Have you been diagnosed as having TMJ or teeth grinding? 
Yes No 
---Yes No __ _ 
Yes No __ _ 
1 ) 
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LEASE COMPLETE EACH QUESTION BY FILLING OUT OR 
CHECKING THE APPROPRIATE ANSWER 
Age: 
Sex: Male Female 
-~~ ~~~ 
Marital Status: Single Married ... ___ Separated ___ _ 
Divorced~~_ Widowcd~~_ Co-Habitating __ _ 
General Medical History: 
4) 
5) 
6) 
7) 
8) 
Have you ever been diagnosed with a cardiac illness? Yes. ___ No~~_ 
Do you have diabetes? Yes ___ No __ _ 
Do you have high blood pressure? Yes __ _ No __ _ 
If yes, are you taking medication to lower it? (e.g.: Cozaar/Losartan, DiovanlValsartan, 
Avapro/lrbpsartan, Atacand/Candesartan) Yes __ _ No 
Do you have high cholesterol? Yes __ _ No __ _ 
9) If yes, what is your total cholesterol level? Less than 200 200 - 239 __ _ 
10) 
11) 
12) 
240 or above 
---
Do you smoke? Yes __ _ No __ _ 
If yes, how much? Less than I pack per day ___ More than 1 pack a day __ _ 
Do you exercise? Yes __ _ No __ _ 
13) Tfyes, is it vigorous or moderate? 
14) 
___ Vigorous (activity causing hard breathing and sweating for at least 20 minutes on 3 or 
more of7 days) 
___ ...;;Moderate (activities such as walking or bicycling lasting at least 30 minutes on 5 or 
more of 7 days) 
Are you overweight? Yes No 
15) If yes, how much? 1 0-20 I bs __ 20--30Ibs ___ Over 30 lbs 
16) 
17) 
Are you currently receiving psychological counseling? Yes __ _ 
Are you currently taking antidepressant medication? (e.g.:Prozac, Zoloft, Paxil, 
Wellbutl"in) Yes 
18) Are you currently taking antianxiety medication? (e.g.: Xanax, Valium, Alivan) 
19) 
20) 
Yes 
Do you have any other major illnesses? (e.g. cancer, organ failure) Yes 
~--
Have you been diagnosed as having 1MJ or teeth grinding? Yes __ _ 
No __ _ 
No __ _ 
No __ _ 
No __ _ 
No 
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MAD-AS 
Marital Status: 
------
Age: ___ _ Sex: 
-----
This questionnaire consists of 43 statements or quartets. After reading each group of 
statements carefully circle the number (0, 1,2 or 3) next to the one statement in each 
group which best describes the way you have been feeling the past week including today. 
There are no right or wrong answers. Carefully read each question before answering. 
1. 0 I never feel a need to get even with those who anger me. 
1 I sometimes feel a need to get even with those who anger me. 
2 I often feel a need to get even with those who anger me. 
3 I always feel a need to get even with those who anger me. 
2. 0 My anger never keeps me up at night. 
1 My anger sometimes keeps me up at night. 
2 My anger often keeps me up at night. 
3 My anger always keeps me at night. 
3. 0 I never have trouble letting go of my anger. 
1 I sometimes have trouble letting go of my anger. 
2 I often have trouble letting go of my anger. 
3 I always have trouble letting go of my anger. 
4. 0 I never anger more frequently than most people. 
1 I sometimes anger more frequently than most people. 
2 I often anger more fTequently than most people. 
3 I always anger more frequently than most people. 
I never get angry without reason. 5. 0 
1 I sometimes get angry without reason. 
2 I often get angry without reason. 
3 I always get angry without reason. 
I am never quick to anger. 6. 0 
1 I am sometimes quick to anger. 
2 I am often quick to anger. 
3 I am always quick to anger. 
Continued on next page ::::::::> 
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7. 0 r never have trouble letting go of things that have angered me in the past. 
1 r sometimes have trouble letting go of things that have angered me in the past. 
2 I often have trouble letting go of things that have angered me in the past. 
3 I always have trouble letting go of things that have angered me in the past. 
8. 0 I never hold grudges against those who have angered me. 
1 I sometimes hold grudges against those who have angered me. 
2 I often hold grudges against those who have angered me. 
3 I always hold grudges against those who have angered me. 
9. 0 I never lose control when angry. 
1 I sometimes lose control when angry. 
2 I often lose control when angry. 
3 I always lose control when angry. 
10.0 I never throw things when I am angry. 
1 I sometimes throw things when I am angry. 
2 I often throw things when I am angry. 
3 I always throw things when I am angry. 
11. 0 I can never control my temper. 
I I can sometimes control my temper. 
2 r can often control my temper. 
3 I can always control my temper. 
12. 0 I never hit those who anger me. 
1 I sometimes hit those who anger me. 
2 I often hit those who anger me. 
3 r always hit those who anger me. 
13.0 I am never a hot head. 
1 I am sometimes a hot head. 
2 I am often a hot head. 
3 I am always a hot head. 
14. 0 I am never critical of others when angry. 
1 I am sometimes critical of others when angry. 
2 I am often critical of others when angry. 
3 I am always critical of others when angry. 
Continued on next page ~ 
15.0 
1 
2 
3 
16.0 
1 
2 
3 
17.0 
1 
2 
3 
18. 0 
1 
2 
3 
19. 0 
1 
2 
3 
20. 0 
1 
2 
3 
21. 0 
1 
2 
3 
22. 0 
1 
2 
3 
I never argue with people without reason. 
I sometimes argue with people without reason. 
I often argue with people without reason. 
I always argue with people without reason. 
I never blame others for my anger. 
I sometimes blame others for my anger. 
I often blame others for my anger. 
I always blame others for my anger. 
I never think about things that anger me. 
I sometimes think about things that anger me. 
I often think about things that anger me. 
I always think about things that anger me. 
When I am angry people never fear me. 
When I am angry people sometimes fear me. 
When I am angry people often fear me. 
When I am angry people always fear me. 
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When I am angry I never have thoughts of hurting others. 
When I am angry I sometimes have thoughts of hurting others. 
When I am angry I often have thoughts of hurting others. 
When I am angry I always have thoughts of hurting others. 
People never intend to anger me. 
People sometimes intend to anger me. 
People often intend to anger me. 
People always intend to anger me. 
My anger never caused me problems in my relationships. 
My anger sometimes caused me problems in my relationships. 
My anger often caused me problems in my relationships. 
My anger always caused me problems in my relationships. 
My anger has never caused me problems on the job. 
My anger has sometimes caused me problems on the job. 
My anger has often caused me problems on the job. 
My anger has always caused me problems on the job. 
Continued on next page ~ 
23. 0 
1 
2 
3 
24. 0 
1 
2 
3 
The behavior of others never causes me to get angry. 
The behavior of others sometimes causes me to get angry. 
The behavior of others often causes me to get angry. 
The behavior of others always causes me to get angry. 
After expressing my anger I never feel guilty. 
After expressing my anger 1 sometimes feel guilty. 
After expressing my anger 1 often feel guilty. 
After expressing my anger I always feel guilty. 
25. 0 1 never tolerate others mistakes. 
1 I sometimes tolerate others mistakes. 
2 I often tolerate others mistakes. 
3 
26.0 
1 
2 
3 
I always tolerate others mistakes. 
1 never insult people when 1 am angry. 
I sometimes insult people when I am angry. 
I often insult people when I am angry. 
I always insult people when I am angry. 
When angry, I never let it show. 27.0 
1 When angry, I sometimes let it show. 
2 When angry, 1 often let it show. 
3 
28. 0 
1 
2 
3 
When angry, I always let it show. 
1 never lose control when angry. 
I sometimes lose control when angry. 
I often lose control when angry. 
I always lose control when angry. 
I never threaten people when angry. 29. 0 
1 I sometimes threaten people when angry. 
2 I often threaten people when angry. 
3 
30. 0 
1 
2 
3 
I always threaten people when angry. 
I am never argumentative. 
I am sometimes argumentative. 
I am often argumentative. 
I am always argumentative. 
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31. 0 
1 
2 
3 
32. 0 
1 
2 
3 
33. 0 
1 
2 
3 
34. 0 
1 
2 
3 
35. 0 
1 
2 
3 
36. 0 
1 
2 
3 
37. 0 
1 
2 
3 
38. 0 
1 
2 
3 
I never tell people when they annoy me. 
I sometimes tell people when they annoy me. 
I often tell people when they annoy me. 
I always tell people when they annoy me. 
When people disagree with me, I never argue. 
When people disagree with me, I sometimes argue. 
When people disagree with me, I often argue. 
When people disagree with me, I always argue. 
1 never feel bitter about things. 
I sometimes feel bitter about things. 
1 often feel bitter about things. 
I always feel bitter about things. 
When provoked, I never hit people. 
When provoked, I sometimes hit people. 
When provoked, I often hit people. 
When provoked, I always hit people. 
When under stress, I never get angry. 
When under stress, I sometimes get angry. 
When under stress, I often get angry. 
When under stress, I always get angry. 
Once angered, I never get over it quickly. 
Once angered, I sometimes get over it quickly. 
Once angered, I often get over it quicldy. 
Once angered, I always get over it quickly. 
I never feel a sense of relief after an angry outburst. 
I sometimes feel a sense of relief after an angry outburst. 
I often feel a sense of relief after an angry outburst. 
I always feel a sense of relief after an angry outburst. 
When angry, I never feel my heati beating faster. 
When angry, I sometimes feel my heart beating faster. 
When angry, I often feel my heart beating faster. 
When angry, I always feel my heart beating faster. 
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39. 0 
1 
2 
3 
40. 0 
1 
2 
3 
41. 0 
1 
2 
3 
42. 0 
1 
2 
3 
43. 0 
1 
2 
3 
When angry, my muscles nevet feel tense. 
When angry, my muscles sometimes feel tense. 
When angry, my muscles often feel tense. 
When angry, my muscles always feel tense. 
When angry, my breathing is never rapid. 
When angry, my breathing is sometimes rapid. 
When angry, my breathing is often rapid. 
When angry, my breathing is always rapid. 
When angry, I never feel restless or agitated. 
When angry, I sometimes feel restless or agitated. 
When angry, I often feel restless or agitated. 
When angry, I always feel restless or agitated. 
When someone offends me I never retaliate. 
When someone offends me I sometimes retaliate. 
When someone offends me I often retaliate. 
When someone offends me I always retaliate. 
In difficult situations, I never get angry. 
In difficult situations, I sometimes get angry. 
In difficult situations, I often get angry. 
In difficult situations, I always get angry. 
Mahan, J.P., & DiTomasso, R. A. (1998) ©, 1998 
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Appendix A 
Instructions 
In addition lo this Item Hooklet you should have a STAXI·2 Rating' Sheet. Before beginning, 
enler YOUI' IWllle, g-ender, ,111r1 age; Imlay's C[;llC: yeal'N of educati()n compleled, your rnariwl 
,lalllN, and your [)cclipatioll in thc spaces prodded al the lOp of Ihe STAXI·2 Rating' SheeL 
Tltb booklet is divided into lhree Pans, Each P,ll'l cont,lins ,I Jll.llniJer of stalenwnLs lhat 
people nse to describe tbeir feelings and behavior, Ple3se note that each ParI haR dijji'rI!111 
dirccliol1s, Carei'lIll), read the directiollS if)r cadI Pan before nxordillg ),our rc,~pon$cs on 
lhe Ral ing Sheet. 
There are no rig-hi or wrong 'Ul.\I\'crs, In responding to each slatement, givc rhe answer thal 
dcscrib(~s you best. DO NOT ER,\SE! If YOll need 1.0 ch:lIlg-c your :ll1SlI'cr, mark an "X" 
Illrollg-It lite incolTccl rCopoJl~C and llicil rill in Ihc correct Ulle, 
Examples 
I. (j) ~ ~ (1) 
~. (D ® @ ® 
!P'AI~ "o}'chulollimil A8S€,9SlI1ellllilesollr/:es, Illt,O 1 (j~(H ~, florida An", LUll, FL 335'!D.ToIH','"'' 1.~OO,3:lI.TESTo \\,\\,\\,.1"11,;,](:,,;0111 
Cnp~Ti~llI ( HI7~J, '~IStl, J~J".j~t l(t~';'i l!lUS, HID!' hy J1:-rdml\l,l-\.ktil.'~'iL';;:,"L1ll'rH RL'~(llIrn·:<. lur. ,\11 (j~h's n:~L'n'L'(t .'Iay nol hl.' n'prlld\l'l'l:d In If!lOk ur in 
p<lr{ in :m,. [(lrIlI or IJ~' ;lIlr JlIl'iill:-t l\'ir/I!!lll \q'fllt'll pl'rl1li'~;(J!llIf P:i,rrjHI:ofl.,iGli ,,\ .. :-:cs,~llInH 1{l:'sUlIl'L'l':-...lnc Thill forlll j~ prilll'l'li in blue ink nil \\'hlr(~ papiT. 
:\11.\' Illht'!' \'!'f~i(tl1 is JIl1,tIlrhorl/.L'fl, 
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Pm'! 1 Directions 
,\ Illllllber or StaLement,< lilaL IJcopk lI~C tu cicscriiJC theJll~eh'Cl are gil'('n below, Read each Sl;llcLllem ami LIien 
hlaci;clI lh ... apl)r<lI)riall' circle Oil the Ratinij Sheel to indicate holl' )'(JII feel righl 1I00e, There arl' 11" riglll OJ' 
wrong' an,\Wl'I'S, Do 1101 'Ilend to" Illuch lim(' 011 an)' one Sl<ltl'lll('nt, ~'Jark Ihe answer Ihm bPsl describes yon!' 
jJrtSfJl! ,J{J(!/i Ilg\'. 
~TJ ror Not af all Fill in C?) foJ' Sotlwll!flat Fill III (;}) for ,\1adl!rart!~)! ,\'Q 
~~----~ --------- ~-------
1, I ,lin I'nriom 
~. [led irriLated 
?, I fcd :tngrv 
How I Feel Right l\Iow 
..J. I ["ellike )'clling at sumebody 
5. I fed lib, breaking Lhings 
Ii. 1<1111 lllad 
7. I feel like banging Oil the table 
fl, I ["ci like hilling s01l1('one 
!), I reel like swearing-
I 0, I I'eel '1I11l0)'<xl 
J J. J ['eel like kicking sOIlIl'I)oriy 
12, I fecllikl' cllr,\in~' OHI lond 
J:l. I reel Ii!;" screaming 
1,1. J leel like IJOunciing sOllwboci)' 
15. r li,:c1like shouting 0111 loud 
Part 2 Directiom 
Fill in '.!l for Very 'WH'" Stl 
Read e,lCh of Ihe 1(lllolI'iug Slalenwnis Ihat people h;1\'(' us eel to describe [hcl11.\('h'('s, al1d t!JCIl blacken LillO 
approprj;ttc circle to indiC<tle how lOll W'IIrT(i/(1' fetcl OT reilCL. There an: 110 right or I\'ronij anSII'CL'S. Do l10t SPPIlr! 
LOO 1I1I)('h lillie on allY 0111.' Sialellleni. i\(,II'); Ihe amll'er I,iml./wsr describes hoI\' ),011 {,,i'llemll.l' feel or 1''';1(1. 
Fill ill (j) fLJf AbllQJI 1H'~ler Fill In (?) for Sometimes Fill in Iii) [OJ' Fill in@[ol',4/mJlJl 
How I Generally Feel 
16. I alll qllick lempered 
17. I hal'c a fiery telnpcr 
I K. J am a hotheaded prl'son 
(D, J get. angry I,hen l'IlI slo\\'ed down hy olileL,' mislakes 
:!ll. I fcci annoycd II'hcn I alll not p;ircil recognition ti)]' doing' gooci 1I'0rk 
21. I fly ofT Ihe h;II1c11e 
22. When I gel mad, I say nasL)' Ihings 
23. II makes me furioll5 when I am criLicizecl ill [ront of 01 hers 
24. When I gel [rn:,lralerl, J ['eelUke hilling sollleone 
25, I kl'i inflirialccllI'hcn I do a !-(oocIjob and gel it pOOl" el'alliaLioll 
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Part 3 iJirectiol1JS 
FI'l:n'Illlc [['('I, allgry or Curious ['nJlll limc 111 lillJe. IJIII [w"pk (\iITer in rhl' lI'a~'s thai the), reacI whl'll thcI' are 
; IIIgT V .. \ I1IH\]I)c1' "I' SI~11('nH.'l)IS ;11'(: Ij~lNl belo\\' I\'hieh PC(lPil' usc 10 describe lheir reactions whell liter feel flllgt')' 
orjil,.ious. R('a[ll'~lCh SIi\Il:IlH'1I1 all(lllH't! blark[,1l the ,Ijll)roprialc circle If) inclicaL(: hoI\' ojif:n you gCJ!!'I'riI~r ITacL 01' 
bdtalT ill lite III;IIII\('\' dl'scribed 1\'llell ~'(l\1 arc li'eliuf,( .mgt), OJ' [uriolls. There arc \to right or wrong alISI\·lT.~. 
no nol spelld Iuo lillIclt time 011 ,Ill)' 01\(' .~laLeTIIl'lli. 
Fill in ~t, for AliI/OIl 1/('I'{'J' FiI1 in (~) for SOIUl'filllm 
How I Generally React or Behave When Angry or Furious ... 
~(i. I WilirolillY leJllllel' 
27. 1 express llJy any;er 
2H. [lake a deep breath .Illd relax 
2~J, [keep IhillgS ill 
:10. I illll patient witll ollier~ 
Fill in <4l fOl' Almost 
:11. Ie someone '\lIl\()~'S me, 1'111 apt to tell him or her how I fed 
:\2. 111')' to calm JlI)'sdf as SOOIl as possible 
.~tL I I)Ollt or sulk 
;\-1. [ cOlllrol [n), urge In eXpt'Cs5 111)' ;llJgT)' feelings 
:lIi. I Ir)' 1.0 SilllJller <1mI'll 
~17, r wjfhdr~l\\~ from people 
3H, [ keep Ill)' cool 
'1~). I make sarcaslic rel1l;(l'ks 10 others 
'10, I Iry lo soothe Ill)' ang'l')' lc'dings 
,II. I boil imide, hUI.I don't sho\\' it 
l~. I control 111)' llL'ital'/o[' 
4:1. I do lhings lib, '\;1[11 doors 
·H, I cl\(leill'Ol' 10 becoJlJe calJJl ,lg';lill 
45, I ll'nd to harbor f(rudges that I don't lell ,1\1),011<' abom 
'Hi, I rail SUlp lll)'self ('rOJll losing Ill)' tempcr 
'17. J ;tIW\(.' wilh nlhcr.s 
48. I reduce lily ;1lIg-er as SOOIl ,IS possible 
'El. r alii se(,rI~tJ~· qllile (Titieal or others 
50. r try lo be tolerant alld 11IH.\t:rslallding 
G J. I sirike 0111 al whalever infuriales lIle 
52. I do SOIlH't hillg relaxing lo callll down 
;'):1. I alll angrier I hall 1 alii willing to adlll it 
il~, I (:onirollllr (\JIg!')' kelill)Di 
Sf). [ .\<l)' nast)' lhill)!,S 
filL I Lf)' to relax 
il7. I'J\\ irritaled a greal deal /lIore Ihan people arc awan: of 
:1 
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Appendix A 
NOTICE OF RESEARCH PARTICIPATION 
The Wyoming Valley Heart Group is currently participating in a 
research study conducted by Philadelphia College of Osteopathic Medicine. 
The study is investigating the relationship between feelings and medical 
problems. If you are a male between the ages of 35 and 63 and have no 
other major medical conditions (such as cancer or organ failure) you may be 
able to participate. The choice to be in this study is completely voluntary 
and all information is anonymous. You will not be identified in any way, 
your health care providers will not have access to the information. In no 
way will your health care be affected whether or not you choose to be in the 
study. You could discontinue your participation at any time without 
consequences. If you decide to participate you will be asked to fill out three 
(3) questionnaires that will take about 20 minutes of your time. You may be 
asked to complete the same questionnaires one week later. Please notifY the 
office staff if you are interested in patiicipating. 
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Appendix A 
NOTICE OF RESEARCH PARTICIPATION 
Dr. Frank Cianci is currently participating in a research study 
conducted by researchers at Philadelphia College of Osteopathic Medicine. 
The study is investigating the relationship between feelings and medical 
problems. Uyou are a male between the ages of35 and 63 and have no 
major medical conditions (such as cancer, heart disease, or organ failure) 
you may be able to participate. The choice to be in this study is completely 
voluntary and all information is anonymous. You will not be identified in 
any way, your health care providers will not have access to the information. 
In no way will your health care be affected whether or not you choose to be 
in the study. You could discontinue your participation at any time without 
consequences. If you decide to participate you will be asked to fill out three 
(3) questionnaires that will take about 20 minutes of your time. You may be 
asked to complete the same questionnaires one week later. Please notifY the 
office staff if you are interested in participating. 
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SCRIPT FOR PARTICIPATION SOLICITATION 
Thank you for your interest in participating in this research study on 
the relationship between feelings and medical problems conducted by 
researchers at Philadelphia College of Osteopathic Medicine. You may be 
included in the study if you are a male between the ages of35 and 63 and 
you have no other major medical illnesses other than a diagnosis of a heart 
ailment and have no psychological problems for which you are currently 
receiving treatment. Your decision to be in this study is completely 
voluntary. You may decide not to participate or discontinue participation at 
any time. In no way will your health care be affected whether or not you 
choose to be in the study. All information will be kept strictly confidential. 
You will not be asked to provide your name on any material, therefore, no 
one will be able to identify you. Your physician and health care workers 
will not have access to this information. 
If you choose to be part of this study, you will be given a packet and 
asked to fill out three questionnaires that take about 20 minutes of your time. 
The first questionnaire asks about your age, sex, marital status, lifestyle, and 
health history. The other two questionnaires ask questions about your 
feelings. If your packet contains two sets of questionnaires, you are 
requested to fill out one packet now, and the one marked "RETEST" ONE 
WEEK later and place it in the postage paid envelope provided and mail it 
back to the researcher. There will be a number on each form that is used to 
match forms should pages get separated and to match mailed in re-test 
packets. 
The questionnaires ask about your thoughts, feelings, and behaviors. 
It is possible that you may learn something about yourself of which you did 
not know before. In the unlikely event that you become uncomfortable or 
upset with your answers to any of these questions, please refer to the 
Introduction letter that contains two local mental health referral telephone 
numbers. You may even choose to contact the principal investigator at the 
number listed on the Introduction Letter or receive a summary of the results 
of the study at the E-mail address listed on the Introduction Letter. 
Thank you very much for you participation in this study. 
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SCRIPT FOR PARTICIPATION SOLICITATION 
Thank you for your interest in participating in this research study on 
the relationship between feelings and medical problems conducted by 
researchers at Philadelphia College of Osteopathic Medicine. You may be 
included in the study if you are a male between the ages of35 and 63 and 
you have no major medical illnesses (such as cancer, heart disease, organ 
failure) and have no psychological problems for which you are currently 
receiving treatment. Your decision to be in this study is completely 
voluntary. You may decide not to participate or discontinue participation at 
any time. Tn no way will your health care be affected whether or not you 
choose to be in the study. All information will be kept strictly confidential. 
You will not be asked to provide your name on any material, therefore, no 
one will be able to identifY you. Your dentist and health care workers will 
not have access to this information. 
If you choose to be part of this study, you will be given a packet and 
asked to fill out three questionnaires that take about 20 minutes of your time. 
The first questionnaire asks about your age, sex, marital status, lifestyle, and 
health history. The other two questionnaires ask questions about your 
feelings. Tfyour packet contains two sets of questionnaires, you are 
requested to fill out one packet now, and the one marked "RETEST" ONE 
WEEK later and place it in the postage paid envelope provided and mail it 
back to the researcher. There will be a number on each form that is used to 
match forms should pages get separated and to match mailed in retest 
packets. 
The questionnaires ask about your thoughts, feelings, and behaviors. 
It is possible that you may learn something about yourself of which you did 
not know before. In the unlikely event that you become uncomfortable or 
upset with your answers to any of these questions, please refer to the 
Introduction letter that contains two local mental health referral telephone 
numbers. You may even choose to contact the principal investigator at the 
number listed on the Introduction Letter or receive a summary of the results 
of the study at the E-mail address listed on the Introduction Letter. 
Thank you very much for you participation in this study. 
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Commitment That Trained Office Siaff Members Who Col1eet Data 
Will Abide By AU RuLes of Confidentiality 
I understand that no participant in this research study will be 
identified. I commit to abiding by all rules of confidentiality in ensuring 
that all participants will remain anonymous and all information will 
remain confidential. 
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Commitment That All Wbo Collect Data Will Abide By All Rules of 
Confiuel1tiality 
I understand that 110 participant in this research study will be identified. I 
commit to abiding by all ndes of confidentiality in ensul'ing that all participants will 
remain anonymous and all infOl1Jlation will remain confidential. 
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Appendix B 
Commitment That AU Who Collect Data Will Abide By An of 
Confidentiality 
I understand that no participant in this research study will be identified. I 
commit to abiding by all rules of confidentiality in ensuring that all participants will 
remain anonymous and all information will remain confidential. 
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Commitment That AU Who Collect Data Will Abide By An Rules of 
Confidentiality 
I understand that no palticipant in thIs research study will be identified. I 
commit to abiding by all rules of confidentiality in ensuring that all paIticipants will 
remain anonymous and all infolmation will remain confidentiaL 
Y'(dfl hi I Jl&.JO alJ ~. 9 -, 3u -/B, 
Signature and Date 
Appendix B 
KIMBERLY $. D'ANDREA, M.S. 
5 AV,-<O'TT C\0811 
MOOKIC, FA 18507 
September I 6, 2003 
Robert A DiTomasso, Ph,D" AB.P,P, 
Professor and Viee Chair, Department of Psychology 
Philadelphia College of Osteopathic Medicine 
4190 Cily Ave.flu8 
Philadelphia, Pa 1913 J 
.lames P. Mahan, PRy.D. 
6 Barley COtHt 
Mariton, NJ 08053 
Dear D(s. DiTomasso aud Mahan, 
Anger and CHD 113 
I am currently a Psy.D. Candidate al Philfldelphia College of Osteopathic 
Medicine. I am writing to you luday to respeccti.lily request pennission to utilize the 
Mahan and DiTomasso Al1ger Scale (l\1AD-AS) as one of the i[~~trumentli in my doctoral 
dissertation. My study is titled "A nonnative study ofthe Mahan and DiTomasso Anger 
Scale (MAD-AS) in an outpatient cardiae population" and il seeks 10 investigate the 
psychometric properlies ofille MAD-AS in an outpatient cardiac population. T also hope 
to add to the growing support tor the correlalion between trait nnger and e01'()nlll'Y heart 
disense. I would be happy to ShiH'C with you the results of my investig'ltion. Please 
indicate if you grant me permission to use the MAD-AS by signing below and pladog 
this letter in the enclosed addressed find stalJ1ped ellvelope. I look fbrward to your reply. 
Thank you very much, 
Sincerely, 
Robert A DiTomasso, Ph.D., AB.P.P. 
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I'IMBERI.Y S. D'ANDRl'.A, M.S. 
September 1o, 2003 
S AI,('o'f'T 
PA 
Robert A DiTomasso, Ph.D" ARP.P, 
Professor Hnd Vice Chnir. Depllfil11cnt ot'Psychology 
Philadelphia College Medicine 
4190 City Avenue 
Philfldelphia, Pa 19131 
James p, Mahan, Psy,D, 
6 Barley Court 
Marlton, NJ 08053 
Dear Drs, DiTomasso and Mahan, 
Anger and CHD 114 
1 am clll'J'entIy a 1'5y.D, Candidate al Philadelphia College of Osteopathic 
Medil:inc. [am writing to YOll today 10 respectJhlly request pennlssion to utilize the 
Mahan and DiTomasso Al1ger Scule (MAD-AS) as aile of the instruments in my doctoral 
dissertation. My study is titled "A normative study ofthe Mahan and DiTomasso Anger 
Scale (MAD-AS) in ,}lJ outpatient cardiae populution" and it seeks to inve$tigate the 
psychometric pl'Opertie:-; of the MAD-AS in an olltpatient cardiae population. I also hope 
to add to Ihe growing support for the correlation belween trait anger and coronary hear! 
disease. I would be happy 10 share with you the results of my illvestigation. Please 
indicate ifyoll grant me permission 10 use Ihe MAD-AS by signing below and placing 
Ilus leller in lhe enclosed addressed and stamped envelope. T look fbrwanllo your reply. 
Thank YOLI VCIY much. 
Sincerely, 
Appendix B 
I«llvUllm,.Y S. D!ANDREA, M.S-
S ALCOTi Cr,o:nl 
Moosrc, Pi\' 18507 
September 16, 2003 
Robert A DiTomasso, Ph,D" ARP_P_ 
Professor and Vice Chair, Department ofPsycho]ogy 
Philadelphia College of OsleoJ'8lhic IVledicine 
4190 City Avenue 
Philadelphia, Pa 19131 
James p, Mahan, Psy_D, 
6 Barley Cmlfl 
Marllon, NJ 011053 
DcaI' Drs_ DiTomasso and Mahull, 
Anger and CHD 114 
I am currently a Psy,D. Candid.,te at Philadelphia College ofOsteopothic 
Medicine. I am writing to you today to respeclfhlly request permission to utilize (he 
Mahan and DiTomasso Anger Scale (MAD-AS) as onc of the instruments in my doctoral 
dissertation. My study is titled "A normative study ofthe Mahan and DiTomasso Anger 
Scnle (MAD-AS) in nn outpatient cardiac population" and it seeks to inveslig;llc the 
psychometric properties of the MAD-AS in an olltpatient cardiac floplliatioll, T also hope 
to add to the growing support t1w the correlation hetwecn trait anger and corona!,y hcmi 
disease. I would be happy to share with YOll the results army invesligation, Please 
indicate if yo II grant me permission to use [hc MAD-AS by signing below und placing 
this ]eller inlhe enclosed addressed and slamped envelope. I look forward (0 your repJy. 
Thank you very much. 
Sincerely, 
